Adtalem Global Education (ATGE) 10-Q 2 Feb 21 2021 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Dec. 31, 2020	Jan. 26, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	001-13988
Entity Registrant Name	Adtalem Global Education Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-3150143
Entity Address, Address Line One	500 West Monroe Street
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60661
City Area Code	866
Local Phone Number	374-2678
Title of 12(b) Security	Common stock
Trading Symbol	ATGE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,153,624
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Entity Central Index Key	0000730464
Amendment Flag	false
New York Stock Exchange
Document Information [Line Items]
Security Exchange Name	NYSE
NYSE Chicago
Document Information [Line Items]
Security Exchange Name	NYSE

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 449,296	$ 500,516	$ 67,282
Investments in marketable securities	10,541	8,968	9,229
Restricted cash	39,425	589	3,465
Accounts receivable, net	91,051	87,042	93,394
Prepaid expenses and other current assets	90,134	95,651	45,275
Current assets held for sale	0	0	171,284
Total current assets	680,447	692,766	389,929
Noncurrent assets:
Property and equipment, net	290,236	286,102	281,975
Operating lease assets	192,954	174,935	187,520
Deferred income taxes	23,489	22,277	10,242
Intangible assets, net	282,518	287,514	292,736
Goodwill	686,557	686,214	686,805
Other assets, net	88,463	78,879	82,850
Noncurrent assets held for sale	0	0	458,553
Total noncurrent assets	1,564,217	1,535,921	2,000,681
Total assets	2,244,664	2,228,687	2,390,610
Current liabilities:
Accounts payable	49,035	46,484	31,457
Accrued payroll and benefits	38,994	48,835	39,088
Accrued liabilities	100,364	104,431	89,507
Deferred revenue	97,400	91,589	51,413
Current operating lease liabilities	51,950	51,644	53,029
Current portion of long-term debt	3,000	3,000	3,000
Current liabilities held for sale	0	0	36,694
Total current liabilities	340,743	345,983	304,188
Noncurrent liabilities:
Long-term debt	284,131	286,115	412,105
Long-term operating lease liabilities	195,840	176,032	180,002
Deferred income taxes	25,792	24,975	24,916
Other liabilities	81,784	82,309	88,945
Noncurrent liabilities held for sale	0	0	82,460
Total noncurrent liabilities	587,547	569,431	788,428
Total liabilities	928,290	915,414	1,092,616
Commitments and contingencies (Note 18)
Redeemable noncontrolling interest	2,595	2,852	3,082
Shareholders' equity:
Common stock, $0.01 par value per share, 200,000 shares authorized; 50,632, 51,871, and 52,953 shares outstanding as of December 31, 2020, June 30, 2020, and December 31, 2019, respectively	810	807	806
Additional paid-in capital	512,102	504,434	496,674
Retained earnings	1,970,813	1,927,568	2,032,788
Accumulated other comprehensive loss	(7,711)	(9,055)	(159,118)
Treasury stock, at cost, 30,389, 28,794, and 27,623 shares as of December 31, 2020, June 30, 2020, and December 31, 2019, respectively	(1,162,235)	(1,113,333)	(1,076,238)
Total shareholders' equity	1,313,779	1,310,421	1,294,912
Total liabilities and shareholders' equity	$ 2,244,664	$ 2,228,687	$ 2,390,610

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
Common Stock, Shares Authorized	200,000	200,000	200,000
Common Stock, Shares Outstanding	50,632	51,871	52,953
Treasury Stock, Shares	30,389	28,794	27,623

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 283,111	$ 266,172	$ 551,352	$ 520,785
Operating cost and expense:
Cost of educational services	126,823	127,258	240,521	255,292
Student services and administrative expense	103,721	96,648	203,899	195,735
Restructuring expense	1,165	1,955	5,388	8,485
Business acquisition and integration expense	11,079	0	24,515	0
Gain on sale of assets	0	0	0	(4,779)
Total operating cost and expense	242,788	225,861	474,323	454,733
Operating income	40,323	40,311	77,029	66,052
Other income (expense):
Interest and dividend income	1,219	1,215	2,223	1,893
Interest expense	(3,736)	(5,066)	(7,428)	(10,394)
Investment gain	1,005	419	1,523	442
Loss on derivative	0	(28,006)	0	(28,006)
Net other expense	(1,512)	(31,438)	(3,682)	(36,065)
Income from continuing operations before income taxes	38,811	8,873	73,347	29,987
Provision for income taxes	(7,223)	(7,570)	(14,313)	(11,276)
Income from continuing operations	31,588	1,303	59,034	18,711
Discontinued operations:
(Loss) income from discontinued operations before income taxes	(11,187)	3,294	(21,271)	411
Benefit from income taxes	2,748	823	5,225	550
(Loss) income from discontinued operations	(8,439)	4,117	(16,046)	961
Net income	23,149	5,420	42,988	19,672
Net loss attributable to redeemable noncontrolling interest	166	105	257	214
Net income attributable to Adtalem Global Education	23,315	5,525	43,245	19,886
Amounts attributable to Adtalem Global Education:
Net income from continuing operations	31,754	1,408	59,291	18,925
Net (loss) income from discontinued operations	(8,439)	4,117	(16,046)	961
Net income attributable to Adtalem Global Education	$ 23,315	$ 5,525	$ 43,245	$ 19,886
Basic:
Continuing operations	$ 0.61	$ 0.03	$ 1.13	$ 0.35
Discontinued operations	(0.16)	0.08	(0.31)	0.02
Net	0.45	0.10	0.83	0.36
Diluted:
Continuing operations	0.61	0.03	1.13	0.34
Discontinued operations	(0.16)	0.08	(0.30)	0.02
Net	$ 0.44	$ 0.10	$ 0.82	$ 0.36
Weighted-average shares outstanding:
Basic shares	52,251	53,890	52,358	54,691
Diluted shares	52,441	54,280	52,622	55,192

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Net income	$ 23,149	$ 5,420	$ 42,988	$ 19,672
Other comprehensive income (loss), net of tax
Gain (loss) on foreign currency translation adjustments	443	17,624	761	(21,870)
Unrealized gain (loss) on marketable securities	2	(3)	1	42
Unrealized gain on interest rate swap	456		582	0
Comprehensive income (loss)	24,050	23,041	44,332	(2,156)
Comprehensive loss attributable to redeemable noncontrolling interest	166	131	257	315
Comprehensive income (loss) attributable to Adtalem Global Education	$ 24,216	$ 23,172	$ 44,589	$ (1,841)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Operating activities:
Net income	$ 42,988	$ 19,672
Loss (income) from discontinued operations	16,046	(961)
Income from continuing operations	59,034	18,711
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	7,652	8,547
Amortization and adjustments to operating lease assets	27,057	21,309
Depreciation	18,325	17,224
Amortization of intangible assets	5,037	5,110
Amortization of deferred debt issuance costs	828	783
Provision for bad debts	5,377	11,436
Deferred income taxes	(583)	2,067
Loss on disposals, accelerated depreciation, and adjustments to property and equipment	1,593	1,100
Realized and unrealized gain on investments	(1,524)	(442)
Realized gain on sale of assets	0	(4,779)
Unrealized loss on derivative	0	28,006
Changes in assets and liabilities:
Accounts receivable	(6,698)	(14,779)
Prepaid expenses and other current assets	5,517	(19,445)
Accounts payable	2,701	(20,906)
Accrued payroll and benefits	(9,832)	(7,576)
Accrued liabilities	1,758	(916)
Deferred revenue	5,811	(44,531)
Operating lease liabilities	(24,962)	(27,549)
Other assets and liabilities	(11,805)	2,390
Net cash provided by (used in) operating activities-continuing operations	85,286	(24,240)
Net cash (used in) provided by operating activities-discontinued operations	(21,893)	10,566
Net cash provided by (used in) operating activities	63,393	(13,674)
Investing activities:
Capital expenditures	(24,175)	(20,311)
Proceeds from sales of marketable securities	1,565	702
Purchases of marketable securities	(1,613)	(753)
Proceeds from sale of assets	0	6,421
Cash received on purchase price adjustment	0	92
Net cash used in investing activities-continuing operations	(24,223)	(13,849)
Net cash used in investing activities-discontinued operations	0	(2,585)
Net cash used in investing activities	(24,223)	(16,434)
Financing activities:
Proceeds from exercise of stock options	56	2,028
Employee taxes paid on withholding shares	(4,073)	(5,232)
Proceeds from stock issued under Colleague Stock Purchase Plan	83	0
Repurchases of common stock for treasury	(44,963)	(100,019)
Borrowings under credit facility	0	160,000
Repayments under credit facility	(1,500)	(146,500)
Proceeds from down payment on seller loan	0	5,200
Payment for purchase of redeemable noncontrolling interest of subsidiary	0	(6,247)
Payment of debt issuance costs	(1,722)	0
Net cash used in financing activities-continuing operations	(52,119)	(90,770)
Net cash used in financing activities-discontinued operations	0	(1,765)
Net cash used in financing activities	(52,119)	(92,535)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	565	(3,037)
Net decrease in cash, cash equivalents and restricted cash	(12,384)	(125,680)
Cash, cash equivalents and restricted cash at beginning of period	501,105	300,467
Cash, cash equivalents and restricted cash at end of period	488,721	174,787
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period	0	104,040
Cash, cash equivalents and restricted cash at end of period	$ 488,721	$ 70,747

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]	Total
Balance at the beginning of period - Net of Tax at Jun. 30, 2019	$ 801	$ 486,061	$ 2,012,902	$ (137,290)	$ (970,944)	$ 1,391,530
Net income attributable to Adtalem Global Education			19,886			19,886
Other comprehensive income (loss), net of tax				(21,828)		(21,828)
Stock-based compensation		8,594				8,594
Net activity from stock-based compensation awards	5	2,019			(5,275)	(3,251)
Repurchases of common shares for treasury					(100,019)	(100,019)
Balance at the end of period - Net of Tax at Dec. 31, 2019	806	496,674	2,032,788	(159,118)	(1,076,238)	1,294,912
Balance at the beginning of period - Net of Tax at Sep. 30, 2019	805	492,151	2,027,263	(176,739)	(1,016,287)	1,327,193
Net income attributable to Adtalem Global Education			5,525			5,525
Other comprehensive income (loss), net of tax				17,621		17,621
Stock-based compensation		3,369				3,369
Net activity from stock-based compensation awards	1	1,154			(187)	968
Repurchases of common shares for treasury					(59,764)	(59,764)
Balance at the end of period - Net of Tax at Dec. 31, 2019	806	496,674	2,032,788	(159,118)	(1,076,238)	1,294,912
Balance at the beginning of period - Net of Tax at Jun. 30, 2020	807	504,434	1,927,568	(9,055)	(1,113,333)	1,310,421
Net income attributable to Adtalem Global Education			43,245			43,245
Other comprehensive income (loss), net of tax				1,344		1,344
Stock-based compensation		7,657				7,657
Net activity from stock-based compensation awards	3	53			(4,073)	(4,017)
Proceeds from stock issued under Colleague Stock Purchase Plan		(42)			134	92
Repurchases of common shares for treasury					(44,963)	(44,963)
Balance at the end of period - Net of Tax at Dec. 31, 2020	810	512,102	1,970,813	(7,711)	(1,162,235)	1,313,779
Balance at the beginning of period - Net of Tax at Sep. 30, 2020	810	508,487	1,947,498	(8,612)	(1,117,212)	1,330,971
Net income attributable to Adtalem Global Education			23,315			23,315
Other comprehensive income (loss), net of tax				901		901
Stock-based compensation		3,648				3,648
Net activity from stock-based compensation awards					(152)	(152)
Proceeds from stock issued under Colleague Stock Purchase Plan		(33)			92	59
Repurchases of common shares for treasury					(44,963)	(44,963)
Balance at the end of period - Net of Tax at Dec. 31, 2020	$ 810	$ 512,102	$ 1,970,813	$ (7,711)	$ (1,162,235)	$ 1,313,779

Nature of Operations

Nature of Operations	6 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	1. Nature of Operations In this Quarterly Report on Form 10-Q, Adtalem Global Education Inc., together with its subsidiaries, is collectively referred to as “Adtalem,” “we,” “our,” “us,” or similar references. Adtalem is a leading workforce solutions provider. We present two reportable segments as follows: Medical and Healthcare Financial Services “Home Office and Other” includes activities not allocated to a reportable segment. See Note 19 “Segment Information” for additional information. Adtalem Education of Brazil (“Adtalem Brazil”), Carrington College (“Carrington”), and DeVry University are presented as discontinued operations and assets held for sale in all periods presented as applicable. See Note 3 “Discontinued Operations and Assets Held for Sale” for additional information. On September 11, 2020, Adtalem entered into a Membership Interest Purchase Agreement (the “Agreement”) with Laureate Education, Inc., a Delaware public benefit corporation (“Seller”), pursuant to which Adtalem has agreed to acquire from Seller all of the issued and outstanding equity interest in Walden e-Learning, LLC, a Delaware limited liability company (“e-Learning”), and its subsidiary, Walden University, LLC, a Florida limited liability company (together with e-Learning, “Walden”), in exchange for a purchase price of $1.48 billion in cash, subject to certain adjustments set forth in the Agreement (the “Acquisition”). Walden owns and operates Walden University, an online for-profit university headquartered in Minneapolis, Minnesota. The Board of Directors of Adtalem (the “Board”) has unanimously approved the Acquisition. The closing of the Acquisition is expected to occur in mid-calendar year 2021 and is subject to certain closing conditions, including regulatory approval by the U.S. Department of Education and the Higher Learning Commission (the “HLC”) and required antitrust approvals. Also on September 11, 2020, to provide future funding for the Acquisition, Adtalem entered into a commitment letter (the “Commitment Letter”) with Morgan Stanley Senior Funding, Inc. (“MSSF”), Barclays Bank PLC (“Barclays”), Credit Suisse AG, Cayman Islands Branch (“CS”) and Credit Suisse Loan Funding LLC (“CSLF” and, together with CS and their respective affiliates, “Credit Suisse”), and MUFG Bank, Ltd. (together with MSSF, Barclays and Credit Suisse, the “Commitment Parties”), pursuant to which the Commitment Parties committed to provide to Adtalem (i)(A) a senior secured term loan facility in an aggregate principal amount of $1 billion (the “Term Facility”) and (B) a senior secured revolving loan facility in an aggregate commitment amount of $400 million (the “Revolving Facility”) and (ii) to the extent one or more series of senior secured notes pursuant to a Rule 144A offering or other private placement in an aggregate principal amount of $650 million are not issued (in escrow or otherwise) prior to the consummation of the Acquisition, a senior secured bridge term loan credit facility in an aggregate principal amount of up to $650 million (together with the Term Facility and the Revolving Facility, the “Facilities”). The proceeds of the Facilities will be used, among other things, to finance the Acquisition, refinance Adtalem’s existing credit agreement, pay fees and expenses related to the Acquisition, and in the case of the Revolving Facility, to finance ongoing working capital and general corporate purposes. The commitments under the Commitment Letter are subject to customary closing conditions. Acquisition and integration costs incurred for this transaction during the three and six months ended December 31, 2020 were $11.1 million and $24.5 million, respectively. On September 16, 2020, Laureate Education, Inc. (“Laureate”) advised Adtalem that Walden University had received a letter from the U.S. Department of Justice (the “DOJ”) indicating that the DOJ, along with several other government agencies, is conducting an investigation into allegations that Walden University may have violated the federal False Claims Act by misrepresenting its compliance with provisions of its Program Participation Agreement with the U.S. Department of Education relating, generally, to potential false representations to the Commission on Collegiate Nursing Education and false advertising to students about (1) the content and cost of Walden’s Masters of Science in Nursing program, or (2) the availability of clinical site placements required for mandatory practicum courses for such program (collectively, the “DOJ Investigation”). Subsequently, Walden disclosed the DOJ Investigation to the HLC. On October 13, 2020, Laureate advised Adtalem that Walden University had received a letter from the HLC notifying Walden University that the HLC seeks to assign a public Governmental Investigation designation to Walden University. On November 9, 2020, the HLC assigned the designation of “Under Governmental Investigation” to Walden University, which will remain in place until the President of the HLC determines the institution has resolved the issues that led to the designation. Pursuant to its access rights under the terms of the Agreement, Adtalem is continuing to conduct its own investigation of the matters addressed in the DOJ and HLC correspondence, including reviewing relevant documents and other information and interviewing relevant Laureate and/or Walden University personnel. As a condition to closing the Acquisition, certain designated regulatory authorities, including the HLC, must consent to the Acquisition. Pursuant to Section 5.05(a) of the Agreement, the parties are required to cooperate and use reasonable best efforts to obtain those designated pre-closing consents from, among others, the HLC. Consistent with the HLC’s policies and procedures, a Governmental Investigation designation by the HLC could delay or prevent the HLC’s approval of a substantive change application to approve the proposed Acquisition. We continue to evaluate these regulatory developments and the potential impact, if any, on our planned Acquisition.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation A full listing of our significant accounting policies is described in Note 2 “Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (“2020 Form 10-K”). We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (which are normal and recurring in nature) considered necessary for a fair presentation have been included. The year-end balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. These consolidated financial statements and accompanying notes should be read in conjunction with our annual consolidated financial statements and the notes thereto included in our 2020 Form 10-K. We use the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the Notes to Consolidated Financial Statements refer to our continuing operations. Certain prior period amounts have been reclassified for consistency with the current period presentation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Although our current estimates contemplate current conditions, including the impact of the novel coronavirus (“COVID-19”) pandemic, and how we anticipate them to change in the future, as appropriate, it is reasonably possible that actual conditions could differ from what was anticipated in those estimates, which could materially affect our results of operations and financial condition. On March 11, 2020, the COVID-19 outbreak was declared a pandemic by the World Health Organization, which recommended containment and mitigation measures worldwide. The outbreak and the response of governmental and public health organizations in dealing with the pandemic included restricting general activity levels within communities, the economy, and operations of our customers. While we have experienced an impact to our business, operations, and financial results as a result of the COVID-19 pandemic, it may have even more far-reaching impacts on many aspects of our operations including the impact on customer behaviors, business operations, our employees, and the market in general. The extent to which the COVID-19 pandemic ultimately impacts our business, financial condition, results of operations, cash flows, and liquidity may differ from management’s current estimates due to inherent uncertainties regarding the duration and further spread of the outbreak, actions taken to contain the virus, as well as, how quickly and to what extent normal economic and operating conditions can resume. Recent Accounting Standards In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13: “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The guidance was issued to provide financial statement users with more decision-useful information about the expected losses on financial instruments by replacing the incurred loss impairment methodology with a methodology that reflects expected credit losses by requiring a broader range of reasonable and supportable information to inform credit loss estimates. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. We adopted this guidance, along with the related clarifications and improvements, effective July 1, 2020 using the modified-retrospective approach without adjusting prior comparative periods. The adoption of this standard did not have a material impact on Adtalem’s Consolidated Financial Statements, and therefore, no adjustments were made to retained earnings.

Discontinued Operations and Ass

Discontinued Operations and Assets Held for Sale	6 Months Ended
	Dec. 31, 2020
Discontinued Operations And Disposal Groups [Abstract]
Discontinued Operations and Assets Held for Sale	3. Discontinued Operations and Assets Held for Sale On December 4, 2018, Adtalem completed the sale of Carrington to San Joaquin Valley College, Inc. (“SJVC”) for de minimis consideration. As the sale represented a strategic shift that had a major effect on Adtalem’s operations and financial results, Carrington is presented in Adtalem’s financial reporting as a discontinued operation. Adtalem has retained certain leases associated with the Carrington operations. Adtalem remains the primary lessee on these leases and subleases to Carrington. Adtalem records the proceeds from these subleases as an offset to operating costs. Adtalem also assigned certain leases to Carrington but remains contingently liable under these leases. Adtalem recorded a pre-tax loss of $11.3 million on the sale of Carrington and transferred $9.9 million of cash and restricted cash balances to Carrington in fiscal year 2019, subject to post-closing adjustments to be completed in fiscal year 2021. On December 11, 2018, Adtalem completed the sale of DeVry University to Cogswell Education, LLC (“Cogswell”) for de minimis consideration. As the sale represented a strategic shift that had a major effect on Adtalem’s operations and financial results, DeVry University is presented in Adtalem’s financial reporting as a discontinued operation. The purchase agreement includes an earn-out entitling Adtalem to payments of up to $20 million over a ten-year period payable based on DeVry University’s free cash flow. In connection with the closing of the sale, Adtalem loaned to DeVry University $10.0 million under the terms of the promissory note, dated as of December 11, 2018 (the “Note”). The Note bears interest at a rate of 4% per annum, payable annually in arrears, and has a maturity date of January 1, 2022. Based on the terms of the Note, DeVry University may make prepayments and may be required to make prepayments on the Note. The Note is recorded within other assets, net on the Consolidated Balance Sheets as of December 31, 2020, June 30, 2020, and December 31, 2019, respectively, except for $5.1 million recorded within prepaid expenses and other current assets as of December 31, 2020 because that amount is due within one year. Adtalem has retained certain leases associated with DeVry University operations. Adtalem remains the primary lessee on these leases and subleases to DeVry University. In addition, Adtalem owns the buildings for certain DeVry University operating and administrative office locations and leases space to DeVry University under one-year operating leases, renewable annually at DeVry University’s option with the exception of one lease which expires December 2023. Adtalem records the proceeds from these leases and subleases as an offset to operating costs. Adtalem also assigned certain leases to DeVry University but remains contingently liable under these leases. Adtalem recorded a pre-tax loss of $22.3 million on the sale of DeVry University and transferred $40.2 million of cash and restricted cash balances to DeVry University in fiscal year 2019. On April 24, 2020, Adtalem completed the sale of Adtalem Brazil to Estácio Participações S.A. (“Estácio”) and Sociedade de Ensino Superior Estaćio de Sá Ltda, a wholly owned subsidiary of Estácio (“Purchaser”), pursuant to the Stock Purchase Agreement dated October 18, 2019. As the sale represented a strategic shift that had a major effect on Adtalem’s operations and financial results, Adtalem Brazil is presented in Adtalem’s financial reporting as a discontinued operation. Pursuant to the terms and subject to the conditions set forth in the purchase agreement, Adtalem sold the issued and outstanding shares of Adtalem Brasil Holding S.A. (a/k/a Adtalem Brazil) to the Purchaser for R$1,920 million, subject to certain post-closing adjustments pursuant to the purchase agreement. Adtalem received $345.9 million in sale proceeds and $56.0 million of Adtalem Brazil cash, for a combined $401.9 million upon the sale. Adtalem Brazil cash balance on the sale date was $88.4 million, resulting in $313.5 million of cash proceeds, net of this cash transferred. In addition, Adtalem received $110.7 million from the settlement of a deal-contingent foreign currency hedge arrangement entered into in connection with the sale of Adtalem Brazil to economically hedge the Brazilian Real sales price through the mitigation of the currency exchange rate risk. Adtalem recorded this settlement as a pre-tax gain on the hedge of $110.7 million in fiscal year 2020. The hedge agreement had a total notional amount of R$2,154 million. The derivative associated with the hedge agreement did not qualify for hedge accounting treatment under ASC 815, and as a result, all changes in fair value were recorded within the income statement. Adtalem recorded a pre-tax unrealized loss on the hedge agreement derivative based on a foreign exchange forward spot rate as of December 31, 2019 of $28.0 million in the second quarter of fiscal year 2020 (see Note 17 “Fair Value Measurements” for additional information) and is included within accrued liabilities on the December 31, 2019 Consolidated Balance Sheet. The following is a summary of balance sheet information of assets and liabilities reported as held for sale as of December 31, 2019, which includes only Adtalem Brazil balances as Carrington and DeVry University were sold prior to that date (in thousands): ​ ​ ​ ​ ​ ​ ​ December 31, ​ ​ 2019 Assets: ​ ​ Current assets: ​ ​ Cash and cash equivalents ​ $ 104,040 Accounts receivable, net ​ 60,494 Prepaid expenses and other current assets ​ 6,750 Total current assets held for sale ​ 171,284 Noncurrent assets: ​ ​ Property and equipment, net ​ ​ 74,939 Operating lease assets ​ 72,665 Deferred income taxes ​ 5,346 Intangible assets, net ​ 114,296 Goodwill ​ 179,199 Other assets, net ​ 12,108 Total noncurrent assets held for sale ​ 458,553 Total assets held for sale ​ $ 629,837 ​ ​ ​ ​ Liabilities: ​ ​ Current liabilities: ​ ​ Accounts payable ​ $ 2,936 Accrued payroll and benefits ​ 13,273 Accrued liabilities ​ 6,484 Deferred revenue ​ 3,096 Current operating lease liabilities ​ 10,905 Total current liabilities held for sale ​ 36,694 Noncurrent liabilities: ​ ​ Long-term operating lease liabilities ​ 62,345 Deferred income taxes ​ 3,929 Other liabilities ​ 16,186 Total noncurrent liabilities held for sale ​ 82,460 Total liabilities held for sale ​ $ 119,154 ​ The following is a summary of income statement information of operations reported as discontinued operations, which includes Adtalem Brazil’s, Carrington’s, and DeVry University’s operations through the date of each respective sale (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Revenue ​ $ — ​ $ 55,153 ​ $ — ​ $ 100,805 ​ Operating cost and expense: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of educational services ​ — ​ 35,717 ​ — ​ 69,665 ​ Student services and administrative expense ​ 11,187 ​ 15,706 ​ 21,271 ​ 30,079 ​ Restructuring expense ​ — ​ 391 ​ — ​ 426 ​ Total operating cost and expense ​ 11,187 ​ 51,814 ​ 21,271 ​ 100,170 ​ Operating (loss) income ​ (11,187) ​ 3,339 ​ (21,271) ​ 635 ​ Other income (expense): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest and dividend income ​ ​ — ​ ​ 761 ​ ​ — ​ ​ 1,739 ​ Interest expense ​ ​ — ​ ​ (806) ​ ​ — ​ ​ (1,963) ​ Net other expense ​ — ​ (45) ​ — ​ (224) ​ (Loss) income from discontinued operations before income taxes ​ ​ (11,187) ​ ​ 3,294 ​ ​ (21,271) ​ ​ 411 ​ Benefit from income taxes ​ 2,748 ​ 823 ​ 5,225 ​ 550 ​ Net (loss) income from discontinued operations attributable to Adtalem ​ $ (8,439) ​ $ 4,117 ​ $ (16,046) ​ $ 961 ​ ​ We continue to incur costs, principally attorney fees, associated with ongoing litigation and settlements related to the DeVry University divestiture, which was completed during fiscal year 2019, and are classified as expense within discontinued operations.

Revenue

Revenue	6 Months Ended
	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue	4. Revenue Revenue is recognized when control of the promised goods or services is transferred to our customers (students and members), in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. The following tables disaggregate revenue by source (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2020 ​ ​ Medical and ​ Financial ​ Consolidated Higher education ​ $ 234,144 ​ $ — ​ $ 234,144 Test preparation/certifications ​ ​ — ​ ​ 31,900 ​ ​ 31,900 Conferences/seminars ​ ​ — ​ ​ 8,178 ​ ​ 8,178 Memberships/subscriptions ​ ​ — ​ ​ 7,798 ​ ​ 7,798 Other ​ ​ 252 ​ ​ 839 ​ ​ 1,091 Total $ 234,396 $ 48,715 $ 283,111 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Six Months Ended December 31, 2020 ​ ​ Medical and Financial ​ Consolidated Higher education $ 452,433 $ — $ 452,433 Test preparation/certifications ​ ​ — ​ ​ 59,176 ​ ​ 59,176 Conferences/seminars ​ ​ — ​ ​ 21,547 ​ ​ 21,547 Memberships/subscriptions ​ ​ — ​ ​ 15,793 ​ ​ 15,793 Other ​ ​ 789 ​ ​ 1,614 ​ ​ 2,403 Total $ 453,222 $ 98,130 $ 551,352 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2019 ​ ​ Medical and ​ Financial ​ Consolidated Higher education ​ $ 214,153 ​ $ — ​ $ 214,153 Test preparation/certifications ​ ​ — ​ ​ 26,938 ​ ​ 26,938 Conferences/seminars ​ ​ — ​ ​ 13,742 ​ ​ 13,742 Memberships/subscriptions ​ ​ — ​ ​ 5,055 ​ ​ 5,055 Other ​ ​ 6,027 ​ ​ 257 ​ ​ 6,284 Total $ 220,180 $ 45,992 $ 266,172 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Six Months Ended December 31, 2019 ​ ​ Medical and Financial ​ Consolidated Higher education ​ $ 415,606 $ — $ 415,606 Test preparation/certifications ​ ​ — ​ ​ 51,909 ​ ​ 51,909 Conferences/seminars ​ ​ — ​ ​ 30,814 ​ ​ 30,814 Memberships/subscriptions ​ ​ — ​ ​ 9,922 ​ ​ 9,922 Other ​ ​ 12,061 ​ ​ 473 ​ ​ 12,534 Total $ 427,667 $ 93,118 $ 520,785 ​ In addition, see Note 19 “Segment Information” for a disaggregation of revenue by geographical region. Performance Obligations and Revenue Recognition Higher education Test preparation/certifications Conferences/seminars Memberships/subscriptions Other Customer contracts generally have separately stated prices for each performance obligation contained in the contract. Therefore, each performance obligation generally has its own standalone selling price. For higher education students, arrangements for payment are agreed to prior to registration of the student’s first academic term. The majority of U.S. students obtain Title IV or other financial aid resulting in institutions receiving a significant amount of the transaction price at the beginning of the academic term. Students utilizing private funding or funding through Adtalem’s credit extension programs (see Note 8 “Accounts Receivable and Credit Losses” for additional information) generally pay after the academic term is complete. For non-higher education customers, payment is typically due and collected at the time a customer places an order. Transaction Price Revenue, or transaction price, is measured as the amount of consideration expected to be received in exchange for transferring goods or services. For higher education, students may receive discounts, scholarships, or refunds, which gives rise to variable consideration. The amounts of discounts or scholarships are applied to individual student accounts when such amounts are awarded. Therefore, the transaction price is reduced directly by these discounts or scholarships from the amount of the standard tuition rate charged. Upon withdrawal, a student may be eligible to receive a refund or partial refund, the amount of which is dependent on the timing of the withdrawal during the academic term. If a student withdraws prior to completing an academic term, federal and state regulations and accreditation criteria permit Adtalem to retain only a set percentage of the total tuition received from such student, which varies with, but generally equals or exceeds, the percentage of the academic term completed by such student. Payment amounts received by Adtalem in excess of such set percentages of tuition are refunded to the student or the appropriate funding source. For contracts with similar characteristics and historical data on refunds, the expected value method is applied in determining the variable consideration related to refunds. Estimates of Adtalem’s expected refunds are determined at the outset of each academic term, based upon actual refunds in previous academic terms. Reserves related to refunds are presented as refund liabilities within accrued liabilities on the Consolidated Balance Sheets. All refunds are netted against revenue during the applicable academic term. Management reassesses collectability throughout the period revenue is recognized by the Adtalem institutions, on a student-by-student basis. This reassessment is based upon new information and changes in facts and circumstances relevant to a student’s ability to pay. Management also reassesses collectability when a student withdraws from the institution and has unpaid tuition charges. Such unpaid charges do not meet the threshold of reasonably collectible and are recognized as revenue on a cash basis. For test preparation and other Financial Services products, the transaction price is equal to the amount charged to the customer, which is the standard rate, less any discounts, and an estimate for returns or refunds. We believe it is probable that no significant reversal will occur in the amount of cumulative revenue recognized when the uncertainty associated with the variable consideration is subsequently resolved. Therefore, the estimate of variable consideration is not constrained. Contract Balances For our higher education institutions, students are billed at the beginning of each academic term and payment is due at that time. Adtalem’s performance obligation is to provide educational services in the form of instruction during the academic term. As instruction is provided, deferred revenue is reduced. A significant portion of student payments are from Title IV financial aid and other programs and are generally received during the first month of the respective academic term. For students utilizing Adtalem’s credit extension programs (see Note 8 “Accounts Receivable and Credit Losses”), payments are generally received after the academic term, and the corresponding performance obligation, is complete. When payments are received, accounts receivable is reduced. For our Financial Services businesses, customers are billed and payment is due at the time of order placement. In most cases, performance obligations are delivered subsequent to payments received. Delivering our performance obligations reduces deferred revenue, and accounts receivable is reduced upon payments received. Becker offers flexible payment plans with terms of up to 12-months as a financing option for the Becker CPA Exam Review Course (see Note 8 “Accounts Receivable and Credit Losses”). In this case, payment is received after satisfying the performance obligation. Revenue of $84.0 million was recognized during the first six months of fiscal year 2021 that was included in the deferred revenue balance at the beginning of fiscal year 2021. Revenue recognized from performance obligations that were satisfied or partially satisfied in prior periods was not material. The difference between the opening and closing balances of deferred revenue includes decreases from revenue recognized during the period, increases from charges related to the start of academic terms beginning during the period, and increases from payments received related to academic terms commencing after the end of the reporting period. Deferred revenue on the Consolidated Balance Sheet as of December 31, 2020 includes $35.5 million of federal financial aid funds that was received in December, primarily at the medical and veterinary schools, which are normally received by these institutions during the first week of January. Practical Expedients As our performance obligations have an original expected duration of one year or less, we have applied the practical expedient (as provided in ASC 606-10-50-14) to not disclose the information in ASC 606-10-50-13, which requires disclosure of the amount of the transaction price allocated to our performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period and when the entity expects to recognize this amount as revenue. All consideration from contracts with customers is included in the transaction price.

Restructuring Charges

Restructuring Charges	6 Months Ended
	Dec. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring Charges	5. Restructuring Charges During the second quarter and first six months of fiscal year 2021, Adtalem recorded restructuring charges primarily related to Adtalem’s home office and ACAMS real estate consolidations. During the second quarter and first six months of fiscal year 2020, Adtalem recorded restructuring charges primarily related to the sale of Becker’s courses for healthcare students and Adtalem’s home office real estate consolidations. When estimating costs of exiting lease space, estimates are made which could differ materially from actual results and result in additional restructuring charges or reversals in future periods. Termination benefit charges represented severance pay and benefits for these employees. Adtalem’s home office is classified as “Home Office and Other” in Note 19 “Segment Information.” Pre-tax restructuring charges by segment were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2020 ​ Six Months Ended December 31, 2020 ​ ​ Real Estate ​ Termination ​ Total ​ Real Estate ​ Termination ​ Total Financial Services $ — $ — $ — ​ $ 1,415 $ — $ 1,415 Home Office and Other ​ 1,165 ​ — ​ 1,165 ​ ​ 3,483 ​ 490 ​ 3,973 Total ​ $ 1,165 ​ $ — ​ $ 1,165 ​ $ 4,898 ​ $ 490 ​ $ 5,388 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2019 ​ Six Months Ended December 31, 2019 ​ ​ Real Estate ​ Termination ​ Total ​ Real Estate ​ Termination ​ Total Medical and Healthcare ​ $ 192 ​ $ 225 ​ $ 417 ​ $ 319 ​ $ 225 ​ $ 544 Financial Services ​ 1,172 ​ (35) ​ 1,137 ​ ​ 2,862 ​ 254 ​ 3,116 Home Office and Other ​ 401 ​ — ​ 401 ​ 4,523 ​ 302 ​ 4,825 Total ​ $ 1,765 ​ $ 190 ​ $ 1,955 ​ $ 7,704 ​ $ 781 ​ $ 8,485 The following table summarizes the separation and restructuring plan activity for the fiscal years 2020 and 2021, for which cash payments are required (in thousands): ​ ​ ​ ​ Liability balance as of June 30, 2019 ​ $ 25,083 ASC 842 (leases) adjustment (1) ​ ​ (25,030) Liability balance as of July 1, 2019 ​ 53 Increase in liability (separation and other charges) ​ 4,955 Reduction in liability (payments and adjustments) ​ (3,573) Liability balance as of June 30, 2020 ​ 1,435 Increase in liability (separation and other charges) ​ 490 Reduction in liability (payments and adjustments) ​ (1,708) Liability balance as of December 31, 2020 ​ $ 217 (1) The liability balance of $0.2 million is recorded as accrued liabilities on the Consolidated Balance Sheet as of December 31, 2020. This liability balance represents costs for employees who have either not yet separated from Adtalem or for whom full severance has not yet been paid. All of these remaining costs are expected to be paid within the next 12 months. We have completed our current restructuring plans. However, we continue to incur restructuring charges or reversals related to exiting leased space from previous restructuring activities. Management may institute future restructuring plans.

Income Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	6. Income Taxes Our effective income tax rates from continuing operations were 18.6% and 19.5% in the three and six months ended December 31, 2020, respectively, and 85.3% and 37.6% in the three and six months ended December 31, 2019, respectively. The effective tax rates in fiscal years 2021 and 2020 reflect the U.S. federal tax rate of 21% adjusted for state and local taxes, foreign rate differences, benefits associated with local tax incentives, changes in valuation allowances and liabilities for uncertain tax positions, and tax benefits on stock-based compensation awards. Additionally, in the second quarter of fiscal year 2020, we were unable to record a tax benefit on a pre-tax unrealized loss of $28.0 million from a derivative contract related to the deal-contingent hedge agreement on the Adtalem Brazil sale completed on April 24, 2020 (see Note 3 “Discontinued Operations and Assets Held for Sale” for additional information). Three of Adtalem’s operating units benefit from local tax incentives: AUC, which operates in St. Maarten, RUSM, which operates in Barbados, and RUSVM, which operates in St. Kitts. AUC’s effective tax rate reflects benefits derived from investment incentives. RUSM and RUSVM each have agreements with their respective domestic governments that exempt them from local income taxation. RUSM has an exemption in Barbados until 2039. RUSVM has an exemption in St. Kitts until 2037. On December 27, 2020, the Consolidated Appropriations Act, 2021 (the “Appropriations Act”) was enacted in response to the COVID-19 pandemic. The Appropriations Act, among other things, temporarily extends through December 31, 2025, certain expiring tax provisions, including look-through treatment of payments of dividends, interest, rents, and royalties received or accrued from related controlled foreign corporations. Additionally, the Appropriations Act enacts new provisions and extends certain provisions originated within the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), enacted on March 27, 2020, including an extension of time for repayment of the deferred portion of employees’ payroll tax through December 31, 2021, and a temporary allowance for full deduction of certain business meals. Adtalem has elected not to defer the employees’ portion of payroll tax. Management is currently evaluating the other provisions of the Appropriations Act, but at present time does not expect that the other provisions of the Appropriations Act would result in a material tax or cash benefit.

Earnings per Share

Earnings per Share	6 Months Ended
	Dec. 31, 2020
Earnings per Share
Earnings per Share	7. Earnings per Share The following table sets forth the computations of basic and diluted earnings per share and stock awards not included in the computation of diluted earnings per share when their effect is anti-dilutive (in thousands, except per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 31,754 ​ $ 1,408 ​ $ 59,291 ​ $ 18,925 ​ Discontinued operations ​ ​ (8,439) ​ ​ 4,117 ​ ​ (16,046) ​ ​ 961 ​ Net ​ $ 23,315 ​ $ 5,525 ​ $ 43,245 ​ $ 19,886 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ 51,654 ​ 53,412 ​ 51,809 ​ 54,215 ​ Unvested participating RSUs ​ 597 ​ 478 ​ 549 ​ 476 ​ Weighted-average basic shares outstanding ​ 52,251 ​ 53,890 ​ 52,358 ​ 54,691 ​ Effect of dilutive stock awards ​ 190 ​ 390 ​ 264 ​ 501 ​ Weighted-average diluted shares outstanding ​ 52,441 ​ 54,280 ​ 52,622 ​ 55,192 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Earnings (loss) per share attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 0.61 ​ $ 0.03 ​ $ 1.13 ​ $ 0.35 ​ Discontinued operations ​ $ (0.16) ​ $ 0.08 ​ $ (0.31) ​ $ 0.02 ​ Net ​ $ 0.45 ​ $ 0.10 ​ $ 0.83 ​ $ 0.36 ​ Diluted: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 0.61 ​ $ 0.03 ​ $ 1.13 ​ $ 0.34 ​ Discontinued operations ​ $ (0.16) ​ $ 0.08 ​ $ (0.30) ​ $ 0.02 ​ Net ​ $ 0.44 ​ $ 0.10 ​ $ 0.82 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average anti-dilutive stock awards ​ ​ 1,168 ​ ​ 1,025 ​ ​ 1,059 ​ ​ 910 ​ ​

Accounts Receivable and Credit

Accounts Receivable and Credit Losses	6 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Accounts Receivable and Credit Losses	8. Accounts Receivable and Credit Losses We categorize our accounts receivable balances as trade receivables or financing receivables. Our trade receivables relate to student or customer balances occurring in the normal course of business. Trade receivables have a term of less than one year and are included in accounts receivable, net on our Consolidated Balance Sheets. Our financing receivables relate to credit extension programs where the student is provided payment terms in excess of one year with their respective school and are included in accounts receivable, net and other assets, net on our Consolidated Balance Sheets. The classification of our accounts receivable balances was as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2020 ​ ​ ​ Gross ​ ​ Allowance ​ ​ Net Trade receivables, current ​ $ 99,811 ​ $ (11,298) ​ $ 88,513 Financing receivables, current ​ ​ 6,830 ​ ​ (4,292) ​ ​ 2,538 Accounts receivable, current ​ $ 106,641 ​ $ (15,590) ​ $ 91,051 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Financing receivables, current ​ $ 6,830 ​ $ (4,292) ​ $ 2,538 Financing receivables, noncurrent ​ ​ 41,165 ​ ​ (13,063) ​ ​ 28,102 Total financing receivables ​ $ 47,995 ​ $ (17,355) ​ $ 30,640 ​ Our financing receivables relate to credit extension programs available to students at Chamberlain, AUC, RUSM, and RUSVM. These credit extension programs are designed to assist students who are unable to completely cover educational costs consisting of tuition, books, and fees, and are available only after all other student financial assistance has been applied toward those purposes. In addition, AUC, RUSM, and RUSVM allow students to finance their living expenses. Repayment plans for financing agreements are developed to address the financial circumstances of the particular student. Interest charges at rates from 3.0% to 12.0% per annum accrue each month on the unpaid balance. Most students are required to begin repaying their loans while they are still in school with a minimum payment level designed to demonstrate their capability to repay, which reduces the possibility of over borrowing, and minimizes interest being accrued on the loan balance. Payments may increase upon completing or departing school. After a student leaves school, the student typically will have a monthly installment repayment plan. In addition, Becker offered an 18-month credit extension program for its Becker CPA Exam Review Course which is considered a financing receivable. Becker is no longer offering credit extension under this program. Instead, Becker is offering flexible payment plans with terms of up to 12-months which is not considered a financing receivable. Credit Quality The primary credit quality indicator for our financing receivables is delinquency. Balances are considered delinquent when contractual payments on the loan become past due. We charge-off financing receivable balances after they have been sent to a third party collector, the timing of which varies by the institution granting the loan, but in most cases is when the financing agreement is at least 181 days past due. Payments are applied first to outstanding interest and then to the unpaid principal balance. The credit quality analysis of financing receivables as of December 31, 2020 was as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortized Cost Basis by Origination Year ​ ​ ​ ​ ​ Prior ​ 2017 ​ 2018 ​ 2019 ​ 2020 ​ 2021 ​ Total 1-30 days past due $ 767 ​ $ 444 $ 589 $ 909 $ 342 $ 23 $ 3,074 31-60 days past due ​ ​ 631 ​ ​ 500 ​ ​ 97 ​ ​ 123 ​ ​ 183 ​ ​ 29 ​ ​ 1,563 61-90 days past due ​ ​ 261 ​ ​ 417 ​ ​ 69 ​ ​ 195 ​ ​ 245 ​ ​ — ​ ​ 1,187 Greater than 90 days past due ​ ​ 7,635 ​ ​ 2,367 ​ ​ 2,200 ​ ​ 1,027 ​ ​ 506 ​ ​ — ​ ​ 13,735 Total past due ​ ​ 9,294 ​ ​ 3,728 ​ ​ 2,955 ​ ​ 2,254 ​ ​ 1,276 ​ ​ 52 ​ ​ 19,559 Current ​ ​ 11,824 ​ ​ 5,389 ​ ​ 3,891 ​ ​ 4,205 ​ ​ 2,271 ​ ​ 856 ​ ​ 28,436 Financing receivables, gross ​ $ 21,118 ​ $ 9,117 ​ $ 6,846 ​ $ 6,459 ​ $ 3,547 ​ $ 908 ​ $ 47,995 ​ The following table includes our financing receivables credit risk profile disclosures for prior periods before we adopted ASC 326 on July 1, 2020 (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Over ​ ​ ​ ​ ​ ​ ​ Total ​ ​ 1-30 Days ​ 31-60 Days ​ 61-90 Days ​ 90 Days ​ Total ​ ​ ​ Financing ​ ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Current ​ Receivables Financing receivables: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2020 ​ $ 7,192 ​ $ 1,755 ​ $ 1,547 ​ $ 13,782 ​ $ 24,276 ​ $ 25,749 ​ $ 50,025 December 31, 2019 ​ $ 3,226 ​ $ 1,601 ​ $ 566 ​ $ 13,407 ​ $ 18,800 ​ $ 31,415 ​ $ 50,215 ​ Allowance for Credit Losses The allowance for credit losses represents an estimate of the lifetime expected credit losses inherent in our accounts receivable balances as of each balance sheet date. In evaluating the collectability of all our accounts receivable balances, we utilize historical events, current conditions, and reasonable and supportable forecasts about the future. For our trade receivables, we primarily use historical loss rates based on a student’s status to determine the allowance for credit losses. As these trade receivables are short-term in nature, management believes a student’s status provides the best credit loss estimate. Students still attending classes and recently graduated are more likely to pay than those who are inactive due to being on a leave of absence or withdrawing from school. For our financing receivables, we primarily use historical loss rates based on an aging schedule specific to each school. As these financing receivables are based on long-term financing agreements offered by Adtalem, management believes that delinquency provides the best credit loss estimate. As the financing receivable balances become further past due, it is less likely we will receive payment, causing our estimate of credit losses to increase. The following tables provide a rollforward of the allowance for credit losses (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2020 Six Months Ended December 31, 2020 ​ ​ Trade ​ Financing ​ Total Trade ​ Financing ​ Total Beginning balance $ 10,634 ​ $ 16,815 $ 27,449 ​ $ 10,825 ​ $ 15,690 $ 26,515 Write-offs ​ ​ (1,143) ​ ​ (1,597) ​ ​ (2,740) ​ ​ (1,902) ​ ​ (1,853) ​ ​ (3,755) Recoveries ​ ​ 205 ​ ​ 85 ​ ​ 290 ​ ​ 391 ​ ​ 125 ​ ​ 516 Provision for credit losses ​ ​ 1,602 ​ ​ 2,052 ​ ​ 3,654 ​ ​ 1,984 ​ ​ 3,393 ​ ​ 5,377 Ending balance ​ $ 11,298 ​ $ 17,355 ​ $ 28,653 ​ $ 11,298 ​ $ 17,355 ​ $ 28,653 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2019 ​ Six Months Ended December 31, 2019 ​ ​ Trade ​ Financing ​ Total ​ Trade ​ Financing ​ Total Beginning balance $ 9,231 ​ $ 9,578 $ 18,809 ​ $ 8,243 ​ $ 6,289 $ 14,532 Write-offs ​ ​ (1,306) ​ ​ (45) ​ ​ (1,351) ​ ​ (2,904) ​ ​ (71) ​ ​ (2,975) Recoveries ​ ​ 181 ​ ​ 4 ​ ​ 185 ​ ​ 504 ​ ​ 28 ​ ​ 532 Provision for credit losses ​ ​ 1,546 ​ ​ 4,336 ​ ​ 5,882 ​ ​ 3,809 ​ ​ 7,627 ​ ​ 11,436 Ending balance ​ $ 9,652 ​ $ 13,873 ​ $ 23,525 ​ $ 9,652 ​ $ 13,873 ​ $ 23,525 ​ Allowance for bad debts on short-term and long-term receivables as of December 31, 2020, June 30, 2020, and December 31, 2019 were $28.7 million, $26.5 million, and $23.5 million, respectively. The increase in the reserve from the year-ago period is driven by an increase in our overall historical loss rates, primarily related to the credit extension programs at the medical and veterinary schools. Accounts receivable, net decreased with an offsetting increase in other assets, net on the Consolidated Balance Sheet as of December 31, 2020 compared to the prior periods presented primarily due to a correction in the methodology on how we classify financing receivable balances between current and noncurrent assets. Other Financing Receivables In connection with the sale of DeVry University, Adtalem loaned $10.0 million to DeVry University under the terms of the Note. The Note bears interest at a rate of 4% per annum, payable annually in arrears, and has a maturity date of January 1, 2022. The DeVry University loan receivable is included on the Consolidated Balance Sheet in other assets, net as of each of December 31, 2020, June 30, 2020, and December 31, 2019, respectively, except for $5.1 million within prepaid expenses and other current assets as of December 31, 2020, and is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 4% per annum. Management has evaluated the collectability of this note and has determined no reserve is necessary. On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep Foundation (“DePaul College Prep”). In connection with the sale, Adtalem holds a mortgage from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The carrying value of the DePaul College Prep loan receivable included in other assets, net on the Consolidated Balance Sheet as of December 31, 2020, June 30, 2020, and December 31, 2019 is $42.0 million, $41.4 million, and $40.8 million, respectively, and was originally determined by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 7% per annum. Management has evaluated the collectability of this note and has determined no reserve is necessary.

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Dec. 31, 2020
Property, Plant And Equipment [Abstract]
Property and Equipment, Net	9. Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, ​ ​ 2020 ​ 2020 ​ 2019 Land $ 44,229 ​ $ 43,246 $ 41,480 Building ​ ​ 317,064 ​ ​ 313,068 ​ ​ 311,185 Equipment ​ ​ 261,722 ​ ​ 248,359 ​ ​ 239,417 Construction in progress ​ ​ 16,636 ​ ​ 12,449 ​ ​ 12,936 Property and equipment, gross ​ ​ 639,651 ​ ​ 617,122 ​ ​ 605,018 Accumulated depreciation ​ (349,415) ​ (331,020) ​ (323,043) Property and equipment, net ​ $ 290,236 ​ $ 286,102 ​ $ 281,975 ​ On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep for $52.0 million. Adtalem received $5.2 million of cash at the time of closing and holds a mortgage, secured by the property, from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The buyer has an option to make prepayments. Due to Adtalem’s involvement with financing the sale, the transaction did not qualify as a sale for accounting purposes. Adtalem continues to maintain the assets associated with the sale on the Consolidated Balance Sheets. We recorded a note receivable of $40.3 million and a financing payable of $45.5 million at the time of the sale, which were classified as other assets, net and other liabilities, respectively, on the Consolidated Balance Sheet. See Note 8 “Accounts Receivable and Credit Losses” for a discussion on the discounting of the note receivable. The $5.2 million received during the first quarter of fiscal year 2020 is classified as a financing activity on the Consolidated Statements of Cash Flows. On September 27, 2019, Adtalem closed on the sale of its Columbus, Ohio, campus facility. Net proceeds from the sale of $6.4 million resulted in a gain on the sale of $4.8 million in the first six months of fiscal year 2020. This gain was recorded at Adtalem’s home office, which is classified as “Home Office and Other” in Note 19 “Segment Information.”

Leases

Leases	6 Months Ended
	Dec. 31, 2020
Lessee Disclosure [Abstract]
Leases	10. Leases We determine if a contract contains a lease at inception. We have entered into operating leases for academic sites, housing facilities, and office space which expire at various dates through June 2032, most of which include options to terminate for a fee or extend the leases for an additional five-year period. The lease term includes options to terminate or extend when it is reasonably certain that the option will be exercised. We elected to account for lease and non-lease components (e.g., common-area maintenance costs) as a single lease component for all operating leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet. We have not entered into any financing leases. Operating lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets represent our right to use an underlying asset during the lease term. Operating lease assets and liabilities are recognized at the lease commencement date based on the present value of future lease payments over the lease term. Operating lease assets are adjusted for any prepaid or accrued lease payments, lease incentives, initial direct costs, and impairments. Our incremental borrowing rate is utilized in determining the present value of the lease payments based upon the information available at the commencement date. Our incremental borrowing rate is determined using a secured borrowing rate for the same currency and term as the associated lease. Operating lease expense is recognized on a straight-line basis over the lease term. As of December 31, 2020, we entered into one additional operating lease that has not yet commenced. The operating lease will commence during the first quarter of fiscal year 2022, has an 11-year lease term, and will result in an additional lease asset The components of lease cost were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Operating lease cost ​ $ 13,964 ​ $ 15,305 ​ $ 26,744 ​ $ 29,008 Sublease income ​ (4,035) ​ (5,060) ​ (8,376) ​ (10,186) Total lease cost ​ $ 9,929 ​ $ 10,245 ​ $ 18,368 ​ $ 18,822 ​ Maturities of lease liabilities by fiscal year as of December 31, 2020 were as follows (in thousands): ​ ​ ​ ​ ​ ​ Operating Fiscal Year ​ Leases 2021 (remaining) ​ $ 32,576 2022 ​ ​ 64,076 2023 ​ ​ 54,260 2024 ​ ​ 40,604 2025 ​ ​ 30,818 Thereafter ​ ​ 70,929 Total lease payments ​ 293,263 Less: imputed interest ​ ​ (45,473) Present value of lease liabilities ​ $ 247,790 ​ Lease term and discount rate were as follows: ​ ​ ​ ​ ​ ​ ​ December 31, ​ ​ 2020 Weighted-average remaining operating lease term (years) ​ ​ 5.8 Weighted-average operating lease discount rate ​ ​ 5.6% ​ Supplemental disclosures of cash flow information related to leases were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, ​ December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts) ​ $ 11,472 ​ $ 12,055 ​ $ 22,899 ​ $ 24,017 Operating lease assets obtained in exchange for operating lease liabilities ​ $ 18,548 ​ $ 787 ​ $ 45,076 ​ $ 5,655 ​ Adtalem maintains agreements to lease either a portion or the full space of three facilities owned by Adtalem to DeVry University with various expiration dates through December 2023. Adtalem maintains agreements to sublease either a portion or the full leased space at 20 of its operating lease locations. Most of these subleases are a result of Adtalem retaining leases associated with restructured lease activities at DeVry University and Carrington prior to their divestitures during fiscal year 2019. All sublease expirations with DeVry University and Carrington coincide with Adtalem’s original head lease expiration dates. At that time, Adtalem will be relieved of its obligations. In addition, Adtalem has entered into subleases with non-affiliated entities for vacated or partially vacated space from restructuring activities. Adtalem’s sublease agreements expire at various dates through December 2025. We record sublease income as an offset against our lease expense recorded on the head lease. For leases which Adtalem vacated or partially vacated space, we recorded estimated restructuring charges in prior periods. Actual results may differ from these estimates, which could result in additional restructuring charges or reversals. Future minimum lease and sublease rental income under these agreements as of December 31, 2020, were as follows (in thousands): ​ ​ ​ ​ ​ Fiscal Year ​ Amount 2021 (remaining) ​ $ 9,344 2022 ​ ​ 17,311 2023 ​ 16,078 2024 ​ 10,261 2025 ​ 5,121 Thereafter ​ ​ 2,038 Total lease and sublease rental income ​ $ 60,153 ​

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	11. Goodwill and Intangible Assets The table below summarizes goodwill balances by reporting unit (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, Reporting Unit ​ 2020 ​ 2020 ​ 2019 Chamberlain ​ $ 4,716 ​ $ 4,716 ​ $ 4,716 AUC ​ 68,321 ​ 68,321 ​ 68,321 RUSM and RUSVM ​ 237,173 ​ 237,173 ​ 237,173 Financial Services ​ 376,347 ​ 376,004 ​ 376,595 Total ​ $ 686,557 ​ $ 686,214 ​ $ 686,805 The table below summarizes goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, Reportable Segment ​ 2020 ​ 2020 ​ 2019 Medical and Healthcare ​ $ 310,210 ​ $ 310,210 ​ $ 310,210 Financial Services ​ 376,347 ​ 376,004 ​ 376,595 Total ​ $ 686,557 ​ $ 686,214 ​ $ 686,805 The table below summarizes the changes in goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and ​ Financial ​ ​ ​ ​ ​ Healthcare ​ Services ​ Total June 30, 2019 ​ $ 310,210 ​ $ 377,046 ​ $ 687,256 Purchase accounting adjustments ​ — ​ (92) ​ (92) Foreign exchange rate changes ​ — ​ (359) ​ (359) December 31, 2019 ​ ​ 310,210 ​ ​ 376,595 ​ ​ 686,805 Foreign exchange rate changes ​ ​ — ​ ​ (591) ​ ​ (591) June 30, 2020 ​ ​ 310,210 ​ ​ 376,004 ​ ​ 686,214 Foreign exchange rate changes ​ — ​ 343 ​ 343 December 31, 2020 ​ $ 310,210 ​ $ 376,347 ​ $ 686,557 ​ The change in the Financial Services segment goodwill balance from June 30, 2020 is the result of a change in the foreign currency exchange rates on the EduPristine goodwill balance recorded in the Indian Rupee compared to the U.S. dollar. Intangible assets consisted of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2020 ​ ​ ​ ​ Gross Carrying ​ Accumulated ​ Weighted-Average ​ ​ Amount ​ Amortization ​ Amortization Period Amortizable intangible assets: ​ ​ ​ ​ ​ ​ ​ Customer relationships ​ $ 68,900 ​ $ (24,444) 10 Years Curriculum/software ​ 11,600 ​ (3,061) 6 Years Course delivery technology ​ 6,700 ​ (2,122) 5 Years Total ​ $ 87,200 ​ $ (29,627) ​ Indefinite-lived intangible assets: ​ ​ ​ ​ ​ Trade names ​ $ 95,705 ​ ​ ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ ​ ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ ​ ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ ​ ​ Intellectual property ​ 13,940 ​ ​ ​ Total ​ $ 224,945 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2020 ​ ​ Gross Carrying ​ Accumulated ​ ​ Amount ​ Amortization Amortizable intangible assets: ​ ​ ​ ​ ​ ​ Customer relationships ​ $ 68,900 ​ $ (21,044) Curriculum/software ​ ​ 11,600 ​ ​ (2,094) Course delivery technology ​ ​ 7,200 ​ ​ (1,952) Total ​ $ 87,700 ​ $ (25,090) Indefinite-lived intangible assets: ​ ​ ​ ​ Trade names ​ $ 95,664 ​ ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ ​ Intellectual property ​ 13,940 ​ ​ Total ​ $ 224,904 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2019 ​ ​ Gross Carrying ​ Accumulated ​ ​ Amount ​ Amortization Amortizable intangible assets: ​ ​ ​ ​ Customer relationships ​ $ 68,900 ​ $ (17,591) Curriculum/software ​ ​ 11,600 ​ ​ (1,128) Course delivery technology ​ ​ 7,200 ​ ​ (1,219) Total ​ $ 87,700 ​ $ (19,938) Indefinite-lived intangible assets: ​ ​ ​ ​ ​ ​ Trade names ​ $ 95,734 ​ ​ ​ Chamberlain Title IV eligibility and accreditations ​ ​ 1,200 ​ ​ ​ AUC Title IV eligibility and accreditations ​ ​ 100,000 ​ ​ ​ Ross Title IV eligibility and accreditations ​ ​ 14,100 ​ ​ ​ Intellectual property ​ ​ 13,940 ​ ​ ​ Total ​ $ 224,974 ​ ​ ​ ​ The table below summarizes the indefinite-lived intangible asset balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, Reportable Segment ​ 2020 ​ 2020 ​ 2019 Medical and Healthcare ​ $ 137,500 ​ $ 137,500 ​ $ 137,500 Financial Services ​ 87,445 ​ 87,404 ​ 87,474 Total ​ $ 224,945 ​ $ 224,904 ​ $ 224,974 ​ Amortization expense for amortized intangible assets was $2.5 million and $5.0 million in the three and six months ended December 31, 2020, respectively, and $2.6 million and $5.1 million in the three and six months ended December 31, 2019, respectively. Estimated intangible asset amortization expense is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ Financial ​ Fiscal Year ​ Services ​ 2021 (remaining) ​ $ 5,036 ​ 2022 ​ 9,943 ​ 2023 ​ 9,792 ​ 2024 ​ 9,509 ​ 2025 ​ 7,933 ​ Thereafter ​ 15,360 ​ Total ​ $ 57,573 ​ ​ All amortizable intangible assets except ACAMS customer relationships are amortized on a straight-line basis. The amount amortized for ACAMS customer relationships is based on the estimated retention of the customers, giving consideration to the revenue and cash flow associated with these existing customers. Indefinite-lived intangible assets related to trade names, Title IV eligibility and accreditations, and intellectual property are not amortized, as there are no legal, regulatory, contractual, economic or other factors that limit the useful life of these intangible assets to the reporting entity. Goodwill and indefinite-lived intangibles are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is May 31. Adtalem has four reporting units that contained goodwill as of the second quarter of fiscal year 2021. These reporting units constitute components for which discrete financial information is available and regularly reviewed by segment management and the Board. If the carrying amount of a reporting unit containing the goodwill exceeds the fair value of that reporting unit, an impairment loss is recognized to the extent the fair value of the reporting unit goodwill is less than the carrying amount of the goodwill, up to the amount of goodwill recorded. In analyzing the results of operations and business conditions of all four reporting units, as of December 31, 2020, it was determined that no triggering event had occurred that would indicate the carrying value of a reporting unit had exceeded its fair value. Adtalem has four reporting units that contained indefinite-lived intangible assets as of the second quarter of fiscal year 2021. For indefinite-lived intangible assets, management first analyzes qualitative factors, including results of operations and business conditions of the four reporting units that contained indefinite-lived intangible assets, significant changes in cash flows at the individual indefinite-lived intangible asset level, if applicable, as well as how much previously calculated fair values exceed carrying values to determine if it is more likely than not that the intangible assets associated with these reporting units have been impaired. In qualitatively assessing the indefinite-lived intangible assets of the four reporting units, it was determined that it was more likely than not that these assets’ fair values exceeded their carrying values as of December 31, 2020. These interim triggering event conclusions were based on the fact that the annual impairment review of Adtalem’s reporting units and indefinite-lived intangible assets resulted in no impairments as of the end of fiscal year 2020, and that no interim events or deviations from planned operating results occurred as of December 31, 2020 that would cause management to reassess these conclusions. Although the COVID-19 pandemic is expected to have a negative effect on the operating results of all four reporting units that contain goodwill and indefinite-lived intangible assets, at this time none of the effects are considered significant enough to create a triggering event. The effects are currently projected to be short-term and would not significantly decrease long-term cash flow projections; however, should economic conditions continue to deteriorate, the revenue and operating results could also deteriorate to the point where a triggering event would exist and require reassessment of the fair values of goodwill and intangible assets and potential impairments. Determining the fair value of a reporting unit or an intangible asset involves the use of significant estimates and assumptions. Management bases its fair value estimates on assumptions it believes to be reasonable at the time, but such assumptions are subject to inherent uncertainty. Actual results may differ from those estimates, which could lead to future impairments of goodwill or intangible assets.

Debt

Debt	6 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt	12. Debt Long-term debt consisted of the following senior secured credit facility (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, ​ ​ 2020 ​ 2020 ​ 2019 Total debt: ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan ​ $ 292,500 ​ $ 294,000 ​ $ 295,500 Revolver ​ — ​ — ​ 125,000 Total principal payments due ​ 292,500 ​ 294,000 ​ 420,500 Deferred debt issuance costs ​ (5,369) ​ (4,885) ​ (5,395) Total amount outstanding ​ 287,131 ​ 289,115 ​ 415,105 Less current portion: ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan ​ (3,000) ​ (3,000) ​ (3,000) Noncurrent portion ​ $ 284,131 ​ $ 286,115 ​ $ 412,105 ​ Scheduled future maturities of long-term debt were as follows (in thousands): ​ ​ ​ ​ ​ ​ Maturity Fiscal Year ​ Payments 2021 (remaining) ​ $ 1,500 2022 ​ 3,000 2023 ​ 3,000 2024 ​ 3,000 2025 ​ 282,000 Total ​ $ 292,500 ​ On April 13, 2018, Adtalem entered into a credit agreement (the “Credit Agreement”) that provides for (1) a $300 million revolving facility (“Revolver”) with a maturity date of April 13, 2023 and (2) a $300 million senior secured Term B loan (“Term B Loan”) with a maturity date of April 13, 2025. We refer to the Revolver and Term B Loan collectively as the “Credit Facility.” The Revolver has availability for currencies other than U.S. dollars of up to $200 million and $100 million available for letters of credit. Subject to certain conditions set forth in the Credit Agreement, the Credit Facility may be increased by $250 million. On December 4, 2020, Adtalem entered into Amendment No. 1 (the “Amendment”) to the Credit Agreement. The Amendment provides for, among other things, certain amendments to the Credit Agreement (i) to permit the issuance of up to $1 billion in debt securities by a newly formed wholly-owned “escrow” subsidiary of Adtalem, the proceeds of which issuance, if any, are expected to be held in escrow and used to finance a portion of the Acquisition and to pay transaction fees and expenses related thereto and (ii) to extend the time period Adtalem has to reinvest proceeds from the disposition of certain Brazilian assets of the Company before the Company is required to prepay the term loans under the Credit Agreement with such proceeds. The Acquisition would satisfy this reinvestment requirement. Interest on the Term B Loan and the Revolver is set based on LIBOR, which is based on observable market transactions. The U.K. Financial Conduct Authority, which regulates LIBOR, has announced that it has commitments from panel banks to continue to contribute to LIBOR through the end of calendar year 2021, but that it will not use its powers to compel contributions beyond such date. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. Management is monitoring their efforts, and evaluating the need for an amendment to the Credit Agreement to accommodate a replacement rate. The Credit Agreement does not specify a replacement rate for LIBOR. Term B Loan For Eurocurrency rate loans, Term B Loan interest is equal to LIBOR or a LIBOR-equivalent rate plus 3%. For base rate loans, Term B Loan interest is equal to the base rate plus 2%. The Term B Loan amortizes in equal quarterly installments of $750,000, with the balance due at maturity on April 13, 2025. As of December 31, 2020, June 30, 2020, and December 31, 2019, the interest rate for borrowings under the Term B Loan facility was 3.15%, 3.18%, and 4.80%, respectively, which approximated the effective interest rate. On March 24, 2020, we executed a pay-fixed, receive-variable interest rate swap agreement (the “Swap”) with a multinational financial institution to mitigate risks associated with the variable interest rate on our Term B Loan debt. We pay interest at a fixed rate of 0.946% and receive variable interest of one-month LIBOR (subject to a minimum of 0.00%), on a notional amount equal to the amount outstanding under the Term B Loan. The effective date of the Swap was March 31, 2020 and settlements with the counterparty occur on a monthly basis. The Swap will terminate on February 28, 2025. The Swap does not specify a replacement rate for LIBOR. Various parties, including government agencies, are seeking to identify an alternative rate to replace LIBOR. Management is monitoring their efforts, and evaluating the need for an amendment to the Swap to accommodate a replacement rate. During the operating term of the Swap, the annual interest rate on the amount of the Term B Loan is fixed at 3.946% (including the impact of our current 3% interest rate margin on LIBOR loans) for the applicable interest rate period. The Swap is designated as a cash flow hedge and as such, changes in its fair value are recognized in accumulated other comprehensive loss on the Consolidated Balance Sheet and are reclassified into the Consolidated Statements of Income within interest expense in the periods in which the hedged transactions affect earnings. Revolver Revolver interest is equal to LIBOR or a LIBOR-equivalent rate for Eurocurrency rate loans or a base rate, plus an applicable rate based on Adtalem’s consolidated leverage ratio, as defined in the Credit Agreement. The applicable rate ranges from 1.75% to 2.75% for Eurocurrency rate loans and from 0.75% to 1.75% for base rate loans. As of December 31, 2019, borrowings under the Revolver were $125 million with a weighted-average interest rate of 3.87%. There were no outstanding borrowings under the Revolver as of each of December 31, 2020 and June 30, 2020. Adtalem had a letter of credit outstanding of $68.4 million as of each of December 31, 2020, June 30, 2020, and December 31, 2019. This letter of credit was posted in the second quarter of fiscal year 2017 in relation to a settlement with the Federal Trade Commission (“FTC”) and requires the letter of credit to be equal to the greater of 10% of DeVry University’s annual Title IV disbursements or $68.4 million for a five-year period. As of December 31, 2020, Adtalem is charged an annual fee equal to 2.25% of the undrawn face amount of the outstanding letters of credit under the Revolver, payable quarterly. Adtalem continues to post the letter of credit in relation to the settlement with the FTC on behalf of DeVry University and is reimbursed by DeVry University for 2.00% of the outstanding amount of this letter of credit. The Credit Agreement also requires payment of a commitment fee equal to 0.40% as of December 31, 2020, of the undrawn portion of the Revolver. The amount undrawn under the Revolver, which includes the impact of the outstanding letters of credit, was $231.6 million as of December 31, 2020. The letter of credit fees and commitment fees are adjustable quarterly, based upon Adtalem’s achievement of certain financial ratios. Debt Issuance Costs Adtalem incurred $9.9 million in fees that were capitalized in relation to the Credit Agreement, $7.1 million of which was related to the Term B Loan facility and $2.7 million of which was related to the Revolver facility. On December 4, 2020, Adtalem entered into Amendment No. 1 to the Credit Agreement and incurred an additional $1.7 million in fees that were capitalized in relation to the Credit Agreement, $1.0 million of which was related to the Term B Loan facility and $0.7 million of which was related to the Revolver facility. The deferred debt issuance costs related to the Term B Loan are presented as a direct deduction from the face amount of the debt, while the deferred debt issuance costs related to the Revolver are classified as other assets, net on the Consolidated Balance Sheets. The deferred debt issuance costs amortization is recorded in interest expense in the Consolidated Statements of Income. The following table summarizes the total deferred debt issuance costs for the Term B Loan and Revolver, which are being amortized over seven years and five years, respectively (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan ​ Revolver ​ Total Deferred debt issuance costs as of June 30, 2020 ​ $ 4,885 ​ $ 1,516 ​ $ 6,401 Deferred debt issuance costs for Credit Agreement ​ 1,015 ​ 707 ​ 1,722 Amortization of deferred debt issuance costs ​ (531) ​ (297) ​ (828) Deferred debt issuance costs as of December 31, 2020 ​ $ 5,369 ​ $ 1,926 ​ $ 7,295 ​ Covenants and Guarantees The Credit Agreement contains customary covenants, including restrictions on our restricted subsidiaries’ ability to merge and consolidate with other companies, incur indebtedness, grant liens or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets. The Credit Agreement contains covenants that, among other things, require maintenance of certain financial ratios. Maintenance of these financial ratios could place restrictions on Adtalem’s ability to pay dividends. Adtalem has not paid a dividend since December 2016. These financial ratios include a consolidated fixed charge coverage ratio, a consolidated leverage ratio, and a U.S. Department of Education financial responsibility ratio based upon a composite score of an equity ratio, a primary reserve ratio, and a net income ratio. Failure to maintain any of these ratios or to comply with other covenants contained in the Credit Agreement would constitute an event of default and could result in termination of the Credit Agreement and require payment of all outstanding borrowings and replacement of outstanding letters of credit. Adtalem was in compliance with the debt covenants as of December 31, 2020. The Term B Loan requires mandatory prepayments equal to a percentage of excess cash flow or equal to the net cash proceeds in excess of $50 million from a disposition which is not reinvested in assets within one-year from the date of disposition, among other mandatory prepayment terms (see the Credit Agreement, as filed under Form 8-K dated April 13, 2018, for additional information and term definitions). No mandatory prepayments have been required or made since the execution of the Credit Agreement. On December 4, 2020, Adtalem entered into the Amendment of the Credit Agreement, which extended the time period Adtalem has to reinvest proceeds from the disposition of certain Brazilian assets of Adtalem until March 25, 2022 before Adtalem is required to prepay the term loans under the Credit Agreement with such proceeds. The Acquisition would satisfy this reinvestment requirement. The stock of all U.S. and certain foreign subsidiaries of Adtalem is pledged as collateral for borrowings under the Credit Agreement. Our borrowings under the Credit Facility are guaranteed by us and all of our domestic subsidiaries (subject to certain exceptions) and secured by a first lien on our assets and the assets of our guarantor subsidiaries (excluding real estate), including capital stock of the subsidiaries.

Redeemable Noncontrolling Inter

Redeemable Noncontrolling Interest	6 Months Ended
	Dec. 31, 2020
Noncontrolling Interest [Abstract]
Redeemable Noncontrolling Interest	13. Redeemable Noncontrolling Interest As of June 30, 2019, Adtalem maintained a 97.9% ownership interest in Adtalem Brazil with the remaining 2.1% owned by members of the Adtalem Brazil senior management group. Since July 1, 2015, Adtalem has had the right to exercise a call option and purchase any remaining Adtalem Brazil stock from Adtalem Brazil management. Likewise, Adtalem Brazil management has had the right to exercise a put option and sell its remaining ownership interest in Adtalem Brazil to Adtalem. In addition, Adtalem maintains a 71% ownership interest in EduPristine with the remaining 29% owned by Kaizen Management Advisors (“Kaizen”), an India-based private equity firm, as of December 31, 2020. Beginning on March 26, 2020, Adtalem has had the right to exercise a call option and purchase any remaining EduPristine stock from Kaizen. Likewise, Kaizen has had the right to exercise a put option and sell up to 33% of its remaining ownership interest in EduPristine to Adtalem. Beginning on March 26, 2022, Kaizen will have the right to exercise a put option and sell its remaining ownership interest in EduPristine to Adtalem. Since the put options are out of the control of Adtalem, authoritative guidance requires the noncontrolling interests, which includes the value of the put options, to be displayed outside of the equity section of the Consolidated Balance Sheets. On July 1, 2019, the Adtalem Brazil management noncontrolling members exercised their put option and sold their remaining ownership interest in Adtalem Brazil to Adtalem resulting in Adtalem owning 100% of Adtalem Brazil until the sale of Adtalem Brazil, which was completed on April 24, 2020. In the first quarter of fiscal year 2020, $6.2 million of redeemable noncontrolling interest was removed from the Consolidated Balance Sheet as a result of the put option exercise. Adtalem has not adjusted the redemption value related to the Kaizen put option as management believes the redemption value has not materially changed since acquiring a majority stake in EduPristine. The adjustment to increase or decrease the EduPristine noncontrolling interest for their respective proportionate share of EduPristine’s profit (loss) flows through the Consolidated Statements of Income each reporting period based on Adtalem’s noncontrolling interest accounting policy. The following is a reconciliation of the redeemable noncontrolling interest balance (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, ​ December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Balance at beginning of period ​ $ 2,761 ​ $ 3,187 ​ $ 2,852 ​ $ 9,543 Net loss attributable to redeemable noncontrolling interest ​ (166) ​ (105) ​ (257) ​ (214) Payment for purchase of redeemable noncontrolling interest of subsidiary ​ ​ — ​ ​ — ​ ​ — ​ ​ (6,247) Balance at end of period ​ $ 2,595 ​ $ 3,082 ​ $ 2,595 ​ $ 3,082 ​

Share Repurchases

Share Repurchases	6 Months Ended
	Dec. 31, 2020
Dividends And Share Repurchase Program [Abstract]
Share Repurchases	14. Share Repurchases On November 8, 2018, we announced that the Board authorized Adtalem’s current share repurchase program, which allows Adtalem to repurchase up to $300 million of its common stock through December 31, 2021. The current share repurchase program commenced in January 2019. Adtalem made share repurchases under the current repurchase program as follows (in thousands, except shares and per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ Life-to-Date ​ ​ December 31, ​ December 31, ​ Current Share ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Repurchase Program Total number of share repurchases ​ ​ 1,473,863 ​ ​ 1,755,160 ​ ​ 1,473,863 ​ ​ 2,673,967 ​ ​ 7,857,294 Total cost of share repurchases ​ $ 44,963 ​ $ 59,764 ​ $ 44,963 ​ $ 100,019 ​ $ 299,732 Average price paid per share ​ $ 30.51 ​ $ 34.05 ​ $ 30.51 ​ $ 37.40 ​ $ 38.15 ​ On February 4, 2020, we announced that the Board authorized Adtalem’s twelfth share repurchase program, which allows Adtalem to repurchase up to $300 million of its common stock through December 31, 2021. The new program will commence when the repurchases from the current program are complete. As of December 31, 2020, $300.3 million of authorized share repurchases were remaining under the current and twelfth share repurchase programs. Repurchases under the current program were suspended on March 12, 2020 due to the economic uncertainty caused by the COVID-19 pandemic. In November 2020, Adtalem resumed repurchases under its current program. The timing and amount of any future repurchases will be determined based on an evaluation of market conditions and other factors. These repurchases may be made through the open market, including block purchases, in privately negotiated transactions, or otherwise. Repurchases will be funded through available cash balances and/or borrowings and may be suspended or discontinued at any time. Shares of stock repurchased under the programs are held as treasury shares. These repurchased shares have reduced the weighted-average number of shares of common stock outstanding for basic and diluted earnings per share calculations.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Dec. 31, 2020
Comprehensive Income, Net Of Tax [Abstract]
Accumulated Other Comprehensive Loss	15. Accumulated Other Comprehensive Loss The following table shows the changes in accumulated other comprehensive loss by component (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, ​ December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Foreign currency translation adjustments ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance ​ $ (1,065) ​ $ (176,883) ​ $ (1,383) ​ $ (137,389) Gain (loss) on foreign currency translation ​ ​ 443 ​ ​ 17,624 ​ ​ 761 ​ ​ (21,870) Ending balance ​ $ (622) ​ $ (159,259) ​ $ (622) ​ $ (159,259) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Marketable securities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ 240 ​ $ 190 ​ $ 242 ​ $ 131 Beginning balance, tax effect ​ ​ (58) ​ ​ (46) ​ ​ (59) ​ ​ (32) Beginning balance, net of tax ​ ​ 182 ​ ​ 144 ​ ​ 183 ​ ​ 99 Unrealized gain (loss) on marketable securities ​ ​ 3 ​ ​ (4) ​ ​ 2 ​ ​ 55 Tax effect ​ ​ (1) ​ ​ 1 ​ ​ (1) ​ ​ (13) Ending balance ​ $ 184 ​ $ 141 ​ $ 184 ​ $ 141 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ (10,232) ​ $ — ​ $ (10,399) ​ $ — Beginning balance, tax effect ​ ​ 2,503 ​ ​ — ​ ​ 2,544 ​ ​ — Beginning balance, net of tax ​ ​ (7,729) ​ ​ — ​ ​ (7,855) ​ ​ — Unrealized gain on interest rate swap ​ ​ 603 ​ ​ — ​ ​ 770 ​ ​ — Tax effect ​ ​ (147) ​ ​ — ​ ​ (188) ​ ​ — Ending balance ​ $ (7,273) ​ $ — ​ $ (7,273) ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total ending balance at December 31 ​ $ (7,711) ​ $ (159,118) ​ $ (7,711) ​ $ (159,118) ​

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Dec. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	16. Stock-Based Compensation Adtalem maintains two stock-based incentive plans: the Amended and Restated Incentive Plan of 2005 and the Fourth Amended and Restated Incentive Plan of 2013. Under these plans, directors, key executives, and managerial employees are eligible to receive incentive stock or nonqualified options to purchase shares of Adtalem’s common stock. The Fourth Amended and Restated Incentive Plan of 2013 and the Amended and Restated Incentive Plan of 2005 also permit the granting of stock appreciation rights, restricted stock units (“RSUs”), performance-based RSUs, and other stock and cash-based compensation. Although options remain outstanding under the 2005 incentive plan, no further stock-based grants will be issued under this plan. The Fourth Amended and Restated Incentive Plan of 2013 and the Amended and Restated Incentive Plan of 2005 are administered by the Compensation Committee of the Board. Options are granted for terms of up to ten years and can vest immediately or over periods of up to five years. The requisite service period is equal to the vesting period. The option price under the plans is the fair market value of the shares on the date of the grant. Stock-based compensation expense is measured at the grant date based on the fair value of the award. Adtalem accounts for stock-based compensation granted to retirement eligible employees that fully vests upon an employee’s retirement under the non-substantive vesting period approach. Under this approach, the entire stock-based compensation expense is recognized at the grant date for stock-based grants issued to retirement eligible employees. For non-retirement eligible employees, stock-based compensation expense is recognized as expense over the employee requisite service period. We account for forfeitures of outstanding but unvested grants in the period they occur. As of December 31, 2020, 3,587,986 shares were authorized for issuance but not issued or subject to outstanding awards under Adtalem’s stock-based incentive plans. The following is a summary of options activity for the six months ended December 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ ​ ​ ​ ​ ​ ​ Remaining ​ Aggregate ​ ​ Number of ​ Weighted-Average ​ Contractual Life ​ Intrinsic Value ​ ​ Options ​ Exercise Price ​ (in years) ​ (in thousands) Outstanding as of July 1, 2020 1,439,630 ​ $ 31.95 ​ ​ ​ ​ Granted 281,075 ​ 32.03 ​ ​ ​ ​ Exercised (5,450) ​ ​ 23.30 ​ ​ ​ ​ Forfeited — ​ ​ — ​ ​ ​ ​ Expired (35,050) ​ ​ 41.84 ​ ​ ​ ​ Outstanding as of December 31, 2020 1,680,205 ​ 31.81 6.60 ​ $ 7,686 Exercisable as of December 31, 2020 1,025,387 ​ $ 29.03 5.42 ​ $ 7,137 ​ The total intrinsic value of options exercised for the six months ended December 31, 2020 and 2019 was $0.1 million and $0.9 million, respectively. The fair value of Adtalem’s stock option awards was estimated using a binomial model. This model uses historical cancellation and exercise experience of Adtalem to determine the option value. It also takes into account the illiquid nature of employee options during the vesting period. The weighted-average estimated grant date fair value of options granted at market price under Adtalem’s stock-based incentive plans during the first six months of fiscal years 2021 and 2020 was $12.23 and $16.98, per share, respectively. The fair value of Adtalem’s stock option grants was estimated assuming the following weighted-average assumptions: ​ ​ ​ ​ ​ ​ ​ ​ ​ Fiscal Year ​ ​ 2021 ​ 2020 ​ Expected life (in years) 6.54 6.51 Expected volatility 39.27 % 37.66 % Risk-free interest rate 0.45 % 1.40 % Dividend yield 0.00 % 0.00 % ​ The expected life of the options granted is based on the weighted-average exercise life with age and salary adjustment factors from historical exercise behavior. Adtalem’s expected volatility is computed by combining and weighting the implied market volatility, the most recent volatility over the expected life of the option grant, and Adtalem’s long-term historical volatility. If factors change and different assumptions are employed in the valuation of stock-based grants in future periods, the stock-based compensation expense that Adtalem records may differ significantly from what was recorded in previous periods. During the first six months of fiscal year 2021, Adtalem granted 564,900 RSUs to selected employees and directors. Of these, 191,850 were performance-based RSUs and 373,050 were non-performance-based RSUs. Performance-based RSUs are earned by the recipients over a three-year period based on achievement of return on invested capital and free cash flow per share. Certain awards are subject to achievement of a minimum level of Adtalem’s earnings before interest, taxes, depreciation, and amortization, calculated on a non-GAAP basis. Non-performance-based RSUs are subject to restrictions which lapse ratably over one three ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ Number of ​ Grant Date ​ ​ RSUs ​ Fair Value Outstanding as of July 1, 2020 767,973 ​ $ 39.42 Granted 564,900 ​ 30.62 Vested (361,728) ​ 34.92 Forfeited (24,630) ​ 38.88 Outstanding as of December 31, 2020 946,515 ​ $ 35.90 ​ The weighted-average estimated grant date fair values of RSUs granted at market price under Adtalem’s stock-based incentive plans during the first six months of fiscal years 2021 and 2020 were $30.62 and $42.66, per share, respectively. The following table shows total stock-based compensation expense included in the Consolidated Statements of Income (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Cost of educational services ​ $ 345 ​ $ 312 ​ $ 738 ​ $ 767 ​ Student services and administrative expense ​ 3,303 ​ 3,012 ​ 6,914 ​ 7,780 ​ ​ ​ 3,648 ​ 3,324 ​ 7,652 ​ 8,547 ​ Income tax benefit ​ (641) ​ (713) ​ (1,167) ​ (3,246) ​ Net stock-based compensation expense ​ $ 3,007 ​ $ 2,611 ​ $ 6,485 ​ $ 5,301 ​ ​ As of December 31, 2020, $29.6 million of total pre-tax unrecognized stock-based compensation expense related to unvested grants is expected to be recognized over a weighted-average period of 2.6 years. The total fair value of options and RSUs vested during the six months ended December 31, 2020 and 2019 was approximately $16.9 million and $13.3 million, respectively. There was no capitalized stock-based compensation cost as of each of December 31, 2020, June 30, 2020, and December 31, 2019. Adtalem has an established practice of issuing new shares of common stock to satisfy stock-based grant exercises. However, Adtalem also may issue treasury shares to satisfy stock-based grant exercises under certain of its stock-based incentive plans.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	17. Fair Value Measurements Adtalem has elected not to measure any assets or liabilities at fair value other than those required to be measured at fair value on a recurring basis. Assets measured at fair value on a nonrecurring basis include goodwill, intangible assets, and assets of businesses where the long-term value of the operations have been impaired. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. The guidance specifies a fair value hierarchy based upon the observability of inputs used in valuation techniques. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. The guidance establishes fair value measurement classifications under the following hierarchy: Level 1 – Level 2 – Observable inputs other than prices included in Level 1, such as quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets. Level 3 –Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable. When available, Adtalem uses quoted market prices to determine fair value, and such measurements are classified within Level 1. In cases where market prices are not available, Adtalem makes use of observable market-based inputs to calculate fair value, in which case the measurements are classified within Level 2. If quoted or observable market prices are not available, fair value is based upon internally developed models that use, where possible, current market-based parameters such as interest rates and yield curves. These measurements are classified within Level 3. Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. A measurement may therefore be classified within Level 3 even though there may be significant inputs that are readily observable. The carrying value of our cash and cash equivalents approximates fair value because of their short-term nature and is classified as Level 1. Adtalem maintains a rabbi trust to fund obligations under a non-qualified deferred compensation plan. The rabbi trust investments in stock and bond mutual funds, which are carried at fair value and classified as marketable securities on the Consolidated Balance Sheets. All investments in marketable securities are recorded at fair value based upon quoted market prices using Level 1 inputs. The fair value of the credit extension programs, which approximates its carrying value, included in accounts receivable, net and other assets, net on the Consolidated Balance Sheets as of December 31, 2020, June 30, 2020, and December 31, 2019 , $34.3 million, and $36.3 million, respectively, is estimated by discounting the future cash flows using current rates for similar arrangements and is classified as Level 2. See Note 8 “Accounts Receivable and Credit Losses” for additional information on these credit extension programs. In connection with the sale of DeVry University, Adtalem loaned $10.0 million to DeVry University under the terms of the Note. The Note bears interest at a rate of 4% per annum, payable annually in arrears, and has a maturity date of January 1, 2022. The fair value of the DeVry University loan receivable approximates its carrying value of $10.0 million for each reporting date. The carrying value is included on the Consolidated Balance Sheet in other assets, net as of each of December 31, 2020, June 30, 2020, and December 31, 2019, respectively, except for $5.1 million within prepaid expenses and other current assets as of December 31, 2020. Fair value is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 4% per annum and is classified as Level 2. On July 31, 2019, Adtalem sold its Chicago, Illinois, campus facility to DePaul College Prep. In connection with the sale, Adtalem holds a mortgage from DePaul College Prep for $46.8 million. The mortgage is due on July 31, 2024 as a balloon payment and bears interest at a rate of 4% per annum, payable monthly. The carrying value of the DePaul College Prep loan receivable, which approximates its fair value, included in other assets, net on the Consolidated Balance Sheet as of December 31, 2020, June 30, 2020, and December 31, 2019 is $42.0 million, $41.4 million, and $40.8 million, respectively. Fair value is estimated by discounting the future cash flows using an average of current rates for similar arrangements, which is estimated at 7% per annum and is classified as Level 2. As of December 31, 2020, June 30, 2020, and December 31, 2019, borrowings under our Credit Facility were $292.5 million, $294.0 million, and $420.5 million, respectively. The carrying value of our long-term debt approximates fair value because the interest rates on these borrowings approximated the effective interest rate and is classified as Level 2. See Note 12 “Debt” for additional information on the Credit Facility. On March 24, 2020, we executed a pay-fixed, receive-variable interest rate swap agreement with a multinational financial institution to fully mitigate risks associated with the variable interest rate on our Term B Loan debt with an effective date of March 31, 2020. The fair value of our Swap is based in part on data received from the counterparty, and represents the estimated amount we would receive or pay to settle the Swap, taking into consideration current and projected future interest rates as well as the creditworthiness of the counterparty, all of which can be validated through readily observable data from external sources, in which case the measurements are classified within Level 2. The fair value of the Swap is represented within other liabilities on the Consolidated Balance Sheet with a balance of $9.6 million and $10.4 million as of December 31, 2020 and June 30, 2020, respectively. See Note 12 “Debt” for additional information on the Swap. In connection with the sale of Adtalem Brazil completed on April 24, 2020, Adtalem entered into a deal-contingent foreign currency hedge arrangement to economically hedge the Brazilian Real denominated sales price through mitigation of the currency exchange rate risk. The hedge agreement had a total notional amount of R$2,154. Adtalem recorded a pre-tax unrealized loss on the hedge agreement derivative based on a foreign exchange forward spot rate as of December 31, 2019 of $28.0 million in the second quarter of fiscal year 2020 and is included within accrued liabilities on the December 31, 2019 Consolidated Balance Sheet. The fair value of this derivative was calculated using observable market-based inputs to a model to calculate fair value, in which case the measurements are classified within Level 2. These model inputs include foreign exchange forward contract spot rates and contract defined point adjustments and settlement prices. As of December 31, 2020, June 30, 2020, and December 31, 2019, there were no assets or liabilities measured at fair value using Level 3 inputs. Assets measured at fair value on a nonrecurring basis include goodwill and indefinite-lived intangibles arising from a business combination. These assets are not amortized and charged to expense over time. Instead, goodwill and indefinite-lived intangibles must be reviewed annually for impairment or more frequently if circumstances arise indicating potential impairment. This impairment review was most recently completed as of May 31, 2020. See Note 11 “Goodwill and Intangible Assets” for additional information on the impairment review, including valuation techniques and assumptions.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	18. Commitments and Contingencies Adtalem is subject to lawsuits, administrative proceedings, regulatory reviews, and investigations associated with financial assistance programs and other matters arising in the normal conduct of its business. As of December 31, 2020, Adtalem believes it has adequately reserved for potential losses. The following is a description of pending legal and regulatory matters that may be considered other than ordinary, routine, and incidental to the business. Descriptions of certain matters from prior SEC filings may not be carried forward in this report to the extent we believe such matters no longer are required to be disclosed or there has not been, to our knowledge, significant activity relating to them. We have recorded accruals for those matters where management believes a loss is probable and can be reasonably estimated as of December 31, 2020. For those matters for which we have not recorded an accrual, their possible impact on Adtalem’s business, financial condition, or results of operations, cannot be predicted at this time. The continued defense, resolution, or settlement of any of the following matters could require us to expend significant resources and could have a material adverse effect on our business, financial condition, results of operations, and cash flows, and result in the imposition of significant restrictions on us and our ability to operate. On April 13, 2018, a putative class action lawsuit was filed by Nicole Versetto, individually and on behalf of others similarly situated, against the Adtalem, DeVry University Inc., and DeVry/New York Inc. (collectively the “Adtalem Parties”) in the Circuit Court of Cook County, Illinois, Chancery Division. The complaint was filed on behalf of herself and three separate classes of similarly situated individuals who were citizens of the State of Illinois and who purchased or paid for a DeVry University program between January 1, 2008 and April 8, 2016. The plaintiff claims that defendants made false or misleading statements regarding DeVry University’s graduate employment rate and asserts causes of action under the Illinois Uniform Deceptive Trade Practices Act, Illinois Consumer Fraud and Deceptive Trade Practices Act, and Illinois Private Business and Vocational Schools Act, and claims of breach of contract, fraudulent misrepresentation, concealment, negligence, breach of fiduciary duty, conversion, unjust enrichment, and declaratory relief as to violations of state law. The plaintiff seeks compensatory, exemplary, punitive, treble, and statutory penalties and damages, including pre-judgment and post-judgment interest, in addition to restitution, declaratory and injunctive relief, and attorneys’ fees. The Adtalem Parties moved to dismiss this complaint on June 20, 2018. On March 11, 2019, the Court granted plaintiff’s motion for leave to file an amended complaint. Plaintiff filed an amended complaint that same day, asserting similar claims, with new lead plaintiff, Dave McCormick. Defendants filed a motion to dismiss plaintiff’s amended complaint on April 15, 2019 and the Court granted Defendants’ motion on July 29, 2019, with leave to amend. The plaintiff has filed an amended complaint on August 26, 2019. On October 18, 2019, defendants’ moved to dismiss this complaint as it is substantially similar to the one the Court previously dismissed. No hearing on the motion to dismiss is currently scheduled. The Court granted a Motion for Preliminary Approval of Class Action Settlement (the “Settlement”) on May 28, 2020. In conjunction with the Settlement, Adtalem was required to establish a settlement fund by placing $44.95 million into an escrow account, which is recorded within prepaid expenses and other current assets on the Consolidated Balance Sheet as of June 30, 2020 and December 31, 2020. Adtalem management determined a loss contingency was probable and reasonably estimable. As such, we also recorded a loss contingency accrual of $44.95 million on the Consolidated Balance Sheet as of June 30, 2020 and charged the contingency loss within discontinued operations in the Consolidated Statement of Income (Loss) for the year ended June 30, 2020. We anticipate the potential payments related to this loss contingency to be made from the escrow account during fiscal year 2021. This loss contingency estimate could differ from actual results and result in additional charges or reversals in future periods. The Court issued an order approving the settlement on October 7, 2020, and dismissed the action with prejudice. On November 2, 2020, Stoltmann Law Offices filed on behalf of objector Jose David Valderrama a notice to appeal the Court’s order approving the settlement. On November 5, 2020, objector Richard Peart filed a notice to appeal the Court’s order approving the settlement. Those appeals have been consolidated before the Appellate Court of Illinois, First District. Objector’s brief is currently due to be filed on February 4, 2021. Plaintiffs’ and the Adtalem Parties’ briefs are due to be filed on March 11, 2021, and Objector’s reply brief is due to be filed on March 25, 2021. On January 25, 2018, the Carlson Law Firm (“Carlson”) filed a lawsuit against Adtalem and DeVry University, Inc., on behalf of 71 individual former DeVry University students in Rangel v. Adtalem and DeVry University, Inc. Carlson filed this lawsuit in the United States District Court for the Western District of Texas. Plaintiffs contend that DeVry University “made deceptive representations about the benefits of obtaining a degree from DeVry University” in violation of Texas state laws and seek full restitution of all monies paid to DeVry University and any student loan lenders, punitive damages, and attorneys’ fees. On May 8, 2018, Carlson filed an amended complaint asserting the same claims which dismissed the claims of 6 students and added claims for 2 other students. The defendants moved to dismiss this complaint on June 5, 2018. On June 27, 2018, Carlson filed a second lawsuit on behalf of 32 former DeVry University students against Adtalem and DeVry University, Inc. in Lindberg v. Adtalem and DeVry University, Inc. Carlson filed this lawsuit in the United States District Court for the Western District of Texas. The allegations are identical to the allegations in the lawsuit Carlson filed on January 25, 2018. Specifically, plaintiffs contend that DeVry University “made deceptive representations about the benefits of obtaining a degree from DeVry University” in violation of Texas state laws and seek full restitution of all monies paid to DeVry University and any student loan lenders, punitive damages, and attorneys’ fees. The defendants moved to dismiss this complaint on August 28, 2018. The court consolidated these two lawsuits on December 10, 2018. The defendants moved to dismiss the consolidated action on December 18, 2018. On January 2, 2019, Carlson filed a motion to intervene on behalf of 13 additional former DeVry University students seeking to join the consolidated lawsuit. The parties re-filed their briefing on the motions to dismiss so that the motion would apply to all three groups of plaintiffs. On April 24, 2019, the Court granted Adtalem’s and DeVry University’s motions to dismiss, with leave to amend. The plaintiffs filed a second amended complaint on June 7, 2019, that dismissed 3 plaintiffs and aggregated the claims of all remaining plaintiffs, now totaling 109, into a single pleading. Defendants moved to dismiss the complaint on July 5, 2019. The motion to dismiss was referred to a magistrate judge. On December 13, 2019, the magistrate judge issued a report and recommendation denying defendants’ motion to dismiss. On January 3, 2020, defendants filed their objections to the report and recommendation on the motion to dismiss, and plaintiffs filed a response to the objections on January 8, 2020. The District Court judge adopted the Magistrate Judge’s report and recommendations on March 12, 2020, and the defendants filed an answer to the complaint on April 10, 2020. In conjunction with the Alvarez v. Adtalem matter referenced below, the parties participated in a mediation on August 4, 2020. On October 14, 2020, through continued negotiations with the mediator, the parties reached a confidential agreement in principal to settle all claims other than for one plaintiff. After finalizing the settlement agreement, the parties filed on December 31, 2020 a joint stipulation of dismissal which dismissed 107 of the 109 plaintiffs. Of the remaining two plaintiffs, one has reached a settlement agreement with defendants in principal and is in the process of executing the necessary settlement documentation. Counsel for plaintiffs moved to withdraw as counsel for the last plaintiff, and on January 4, 2021, the Court granted plaintiffs’ motion to withdraw as counsel. On April 4, 2019, the Carlson Law Firm sent notice pursuant to California Legal Remedies Act, Civil Code § 1750, of 105 individuals who purportedly have claims against DeVry University and Adtalem based on allegedly deceptive comments made about the benefits of obtaining a DeVry University degree; specifically, that 90% of graduates obtained a job in their chosen field of study within six months of graduation, and that graduates were paid more than graduates of other universities. On July 16, 2019, the Carlson Law Firm filed a lawsuit in the United States District Court for the Northern District of California – San Jose Division against Adtalem and DeVry University on behalf of 102 individual former DeVry University students in Alvarez v. Adtalem and DeVry University, Inc. The plaintiffs contend that defendants misrepresented the benefits of graduating from DeVry University and falsely and misleadingly advertised the employment rate and income rate of their graduates to induce potential students to purchase educational products and services, and to remain students through graduation. The lawsuit seeks exemplary damages, restitution, economic damages, punitive damages, pre- and post-judgment interest, attorneys’ fees and the cost of suit. The plaintiffs brought claims for fraud by misrepresentation, fraud by concealment, negligent misrepresentation, civil theft, violation of the California Consumer Legal Remedies Act, violation of California’s Unfair Competition Law, and violation of California’s False Advertising Law. Defendants filed a motion to dismiss the complaint on October 1, 2019. On December 16, 2019, the Court granted in part and denied in part the motion to dismiss. Defendants filed an answer to the complaint on January 13, 2020. Plaintiffs filed an amended complaint on January 31, 2020, which added 12 additional plaintiffs and dismissed 2 others. Defendants filed an amended answer on March 2, 2020. The parties participated in a court-ordered mediation on August 4, 2020. On October 14, 2020, through continued negotiations with the mediator, the parties reached a confidential agreement in principal to settle all claims other than for three plaintiffs. After finalizing the settlement agreement, the parties filed on December 31, 2020 a joint stipulation of dismissal which dismissed 108 of the 112 plaintiffs. On January 19, 2021, the Court entered an order dismissing with prejudice all the claims for the 108 plaintiffs. Of the remaining four plaintiffs, one has reached a settlement agreement with defendants in principal and is in the process of executing the necessary settlement documentation. On December 9, 2020, counsel for plaintiffs moved to withdraw as counsel for the final three plaintiffs, and the parties are awaiting a ruling from the Court on that motion. On June 21, 2018, Stoltmann Law Offices filed a lawsuit against Adtalem in Cook County Circuit Court, alleging that Adtalem breached a contract with Stoltmann Law Offices to pay filing fees associated with arbitration claims Stoltmann Law Offices has filed with the Judicial Arbitration and Mediation Services, Inc. (“JAMS”). Stoltmann Law Offices is seeking specific performance from the court. Adtalem moved to dismiss this complaint on August 3, 2018. Prior to the court ruling on Adtalem’s motion to dismiss, Stoltmann Law Offices and 399 individuals filed an amended complaint on August 9, 2018, asserting claims for specific performance, declaratory judgment and a petition to compel arbitration. Adtalem moved to dismiss the amended complaint on August 31, 2018. The court granted Adtalem’s motion to dismiss on November 30, 2018, but granted plaintiffs leave to file a second amended complaint. A single Stoltmann Law Offices is representing hundreds of individuals who have filed claims with JAMS alleging fraud-based claims based on DeVry University’s graduate employment statistics. Stoltmann Law Offices has paid the filing fees for certain of these arbitrations to move forward. JAMS has sent commencement letters in several waves. Respondents have filed answers in response to certain of these arbitration demands. These arbitrations are in various stages of litigation. On or about April 1, 2019, Adtalem, Chamberlain and DeVry University received similar Civil Investigative Demands (“CID”) from the DOJ. The CIDs were issued pursuant to a False Claims Act inquiry concerning allegations that Adtalem, in particular Chamberlain and Adtalem’s former subsidiary DeVry University, submitted or caused the submission of false claims to the U.S. Department of Defense and U.S. Department of Veteran Affairs for federal funds under the GI Bill Programs and Tuition Assistance Program from 2011 to the date of the CIDs. It is specifically alleged that Chamberlain and DeVry University engaged in unlawful recruitment tactics, and provided incentive payments based directly or indirectly on securing federal financial aid. Adtalem cooperated with this DOJ inquiry and provided documents and other information requested by the DOJ. On February 27, 2020, the DOJ notified the U.S. District Court for the Northern District of Georgia that it would decline to intervene in two qui tam False Claims Act actions filed by former DeVry University employees related to the subject matter of the CIDs. Those actions were unsealed on March 2, 2020. The complaints had been filed by former employees Ashley Vandiver (2017 complaint) and Laura Moriarty (2018 complaint). Both complaints sought damages and relief allowed by law under the False Claims Act, 31 U.S.C. § 3729 et seq impacted by the Moriarty settlement. Adtalem, DeVry University and Vandiver are in discussions to resolve the Vandiver matter.

Segment Information

Segment Information	6 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Segment Information	19. Segment Information Beginning in the first quarter of fiscal year 2020, Adtalem Brazil operations were classified as discontinued operations. See Note 3 “Discontinued Operations and Assets Held for Sale” for additional information. Segment information presented excludes the results of Adtalem Brazil. Adtalem eliminated its Business and Law reportable segment during the first quarter of fiscal year 2020 when Adtalem Brazil was classified as discontinued operations. Discontinued operations assets are included in the table below to reconcile to total consolidated assets presented on the Consolidated Balance Sheets. We present two reportable segments as follows: Medical and Healthcare Financial Services These segments are consistent with the method by which the Chief Operating Decision Maker (Adtalem’s Chairman, President and Chief Executive Officer) evaluates performance and allocates resources. Performance evaluations are based on each segment’s operating income excluding special items. Operating income excludes special items, which consists of restructuring expense, business acquisition and integration expense, and gain on sale of assets. Adtalem’s management excludes these items from its review of the results of the operating segments for purposes of measuring segment profitability and allocating resources. Intersegment sales are accounted for at amounts comparable to sales to nonaffiliated customers and are eliminated in consolidation. “Home Office and Other” includes activities not allocated to a reportable segment and is included to reconcile segment results to the Consolidated Financial Statements. Segments may have allocated depreciation expense related to depreciable assets reported as an asset in a different segment. The accounting policies of the segments are the same as those described in Note 2 “Summary of Significant Accounting Policies.” Summary financial information by reportable segment is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Revenue: ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 234,396 ​ $ 220,180 ​ $ 453,222 ​ $ 427,667 ​ Financial Services ​ 48,715 ​ 45,992 ​ 98,130 ​ 93,118 ​ Total consolidated revenue ​ $ 283,111 ​ $ 266,172 ​ $ 551,352 ​ $ 520,785 ​ Operating income excluding special items: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 51,290 ​ $ 41,600 ​ $ 104,300 ​ $ 70,227 ​ Financial Services ​ 7,793 ​ 5,679 ​ 16,480 ​ 9,786 ​ Home Office and Other ​ (6,516) ​ (5,013) ​ (13,848) ​ (10,255) ​ Total consolidated operating income excluding special items ​ ​ 52,567 ​ ​ 42,266 ​ ​ 106,932 ​ ​ 69,758 ​ Reconciliation to Consolidated Financial Statements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Restructuring expense ​ (1,165) ​ (1,955) ​ (5,388) ​ (8,485) ​ Business acquisition and integration expense ​ ​ (11,079) ​ — ​ ​ (24,515) ​ — ​ Gain on sale of assets ​ ​ — ​ — ​ ​ — ​ ​ 4,779 ​ Total consolidated operating income ​ ​ 40,323 ​ ​ 40,311 ​ ​ 77,029 ​ ​ 66,052 ​ Net other expense ​ (1,512) ​ (31,438) ​ (3,682) ​ (36,065) ​ Total consolidated income from continuing operations before income taxes ​ $ 38,811 ​ $ 8,873 ​ $ 73,347 ​ $ 29,987 ​ Segment assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 987,276 ​ $ 913,359 ​ $ 987,276 ​ $ 913,359 ​ Financial Services ​ 590,045 ​ 574,813 ​ 590,045 ​ 574,813 ​ Home Office and Other ​ 667,343 ​ 272,601 ​ 667,343 ​ 272,601 ​ Discontinued Operations ​ — ​ 629,837 ​ — ​ 629,837 ​ Total consolidated assets ​ $ 2,244,664 ​ $ 2,390,610 ​ $ 2,244,664 ​ $ 2,390,610 ​ Capital expenditures: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 5,623 ​ $ 6,367 ​ $ 14,889 ​ $ 12,834 ​ Financial Services ​ 2,344 ​ 873 ​ 4,471 ​ 1,412 ​ Home Office and Other ​ 1,765 ​ 2,635 ​ 4,815 ​ 6,065 ​ Total consolidated capital expenditures ​ $ 9,732 ​ $ 9,875 ​ $ 24,175 ​ $ 20,311 ​ Depreciation expense: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 7,690 ​ $ 7,540 ​ $ 15,063 ​ $ 14,771 ​ Financial Services ​ 800 ​ 588 ​ 1,529 ​ 882 ​ Home Office and Other ​ 860 ​ 703 ​ 1,733 ​ 1,571 ​ Total consolidated depreciation expense ​ $ 9,350 ​ $ 8,831 ​ $ 18,325 ​ $ 17,224 ​ Intangible asset amortization expense: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Financial Services ​ $ 2,519 ​ $ 2,576 ​ $ 5,037 ​ $ 5,110 ​ Total consolidated intangible asset amortization expense ​ $ 2,519 ​ $ 2,576 ​ $ 5,037 ​ $ 5,110 ​ Adtalem conducts its educational and financial services operations in the U.S., Barbados, St. Kitts, St. Maarten, India, Europe, China, Canada, and the Middle East. Revenue and long-lived assets by geographic area are as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Revenue from unaffiliated customers: ​ ​ ​ ​ ​ ​ ​ ​ ​ Domestic operations ​ $ 176,911 ​ $ 160,410 ​ $ 349,556 ​ $ 312,445 ​ International operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Barbados, St. Kitts, and St. Maarten ​ 92,419 ​ 94,705 ​ 177,480 ​ 185,675 ​ Other ​ 13,781 ​ 11,057 ​ 24,316 ​ 22,665 ​ Total international ​ 106,200 ​ 105,762 ​ 201,796 ​ 208,340 ​ Total consolidated revenue ​ $ 283,111 ​ $ 266,172 ​ $ 551,352 ​ $ 520,785 ​ Long-lived assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Domestic operations ​ $ 215,797 ​ $ 200,257 ​ $ 215,797 ​ $ 200,257 ​ International operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Barbados, St. Kitts, and St. Maarten ​ 161,825 ​ 162,813 ​ 161,825 ​ 162,813 ​ Other ​ 1,077 ​ 1,755 ​ 1,077 ​ 1,755 ​ Total international ​ 162,902 ​ 164,568 ​ 162,902 ​ 164,568 ​ Total consolidated long-lived assets ​ $ 378,699 ​ $ 364,825 ​ $ 378,699 ​ $ 364,825 ​ ​ Prior period amounts within domestic operations and other international operations revenue in the above table have been reclassified for consistency with the current period presentation. We previously classified certain sales dependent upon the location of the legal entity reporting the sale. We have changed our methodology to classify these sales within the geographic area category where the sale originates. We believe this better reflects the usefulness of this disclosure. No one customer accounted for more than 10% of Adtalem’s consolidated revenue for all periods presented.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation A full listing of our significant accounting policies is described in Note 2 “Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 (“2020 Form 10-K”). We have prepared the accompanying unaudited consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial statements and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (which are normal and recurring in nature) considered necessary for a fair presentation have been included. The year-end balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. These consolidated financial statements and accompanying notes should be read in conjunction with our annual consolidated financial statements and the notes thereto included in our 2020 Form 10-K. We use the same accounting policies in preparing quarterly and annual financial statements. Unless otherwise noted, amounts presented within the Notes to Consolidated Financial Statements refer to our continuing operations. Certain prior period amounts have been reclassified for consistency with the current period presentation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Although our current estimates contemplate current conditions, including the impact of the novel coronavirus (“COVID-19”) pandemic, and how we anticipate them to change in the future, as appropriate, it is reasonably possible that actual conditions could differ from what was anticipated in those estimates, which could materially affect our results of operations and financial condition. On March 11, 2020, the COVID-19 outbreak was declared a pandemic by the World Health Organization, which recommended containment and mitigation measures worldwide. The outbreak and the response of governmental and public health organizations in dealing with the pandemic included restricting general activity levels within communities, the economy, and operations of our customers. While we have experienced an impact to our business, operations, and financial results as a result of the COVID-19 pandemic, it may have even more far-reaching impacts on many aspects of our operations including the impact on customer behaviors, business operations, our employees, and the market in general. The extent to which the COVID-19 pandemic ultimately impacts our business, financial condition, results of operations, cash flows, and liquidity may differ from management’s current estimates due to inherent uncertainties regarding the duration and further spread of the outbreak, actions taken to contain the virus, as well as, how quickly and to what extent normal economic and operating conditions can resume.
Recent Accounting Standards	Recent Accounting Standards In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13: “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The guidance was issued to provide financial statement users with more decision-useful information about the expected losses on financial instruments by replacing the incurred loss impairment methodology with a methodology that reflects expected credit losses by requiring a broader range of reasonable and supportable information to inform credit loss estimates. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. We adopted this guidance, along with the related clarifications and improvements, effective July 1, 2020 using the modified-retrospective approach without adjusting prior comparative periods. The adoption of this standard did not have a material impact on Adtalem’s Consolidated Financial Statements, and therefore, no adjustments were made to retained earnings.

Discontinued Operations and A_2

Discontinued Operations and Assets Held for Sale (Tables)	6 Months Ended
	Dec. 31, 2020
Discontinued Operations And Disposal Groups [Abstract]
Balance Sheet and Income Statement Information of Discontinued Operations	The following is a summary of balance sheet information of assets and liabilities reported as held for sale as of December 31, 2019, which includes only Adtalem Brazil balances as Carrington and DeVry University were sold prior to that date (in thousands): ​ ​ ​ ​ ​ ​ ​ December 31, ​ ​ 2019 Assets: ​ ​ Current assets: ​ ​ Cash and cash equivalents ​ $ 104,040 Accounts receivable, net ​ 60,494 Prepaid expenses and other current assets ​ 6,750 Total current assets held for sale ​ 171,284 Noncurrent assets: ​ ​ Property and equipment, net ​ ​ 74,939 Operating lease assets ​ 72,665 Deferred income taxes ​ 5,346 Intangible assets, net ​ 114,296 Goodwill ​ 179,199 Other assets, net ​ 12,108 Total noncurrent assets held for sale ​ 458,553 Total assets held for sale ​ $ 629,837 ​ ​ ​ ​ Liabilities: ​ ​ Current liabilities: ​ ​ Accounts payable ​ $ 2,936 Accrued payroll and benefits ​ 13,273 Accrued liabilities ​ 6,484 Deferred revenue ​ 3,096 Current operating lease liabilities ​ 10,905 Total current liabilities held for sale ​ 36,694 Noncurrent liabilities: ​ ​ Long-term operating lease liabilities ​ 62,345 Deferred income taxes ​ 3,929 Other liabilities ​ 16,186 Total noncurrent liabilities held for sale ​ 82,460 Total liabilities held for sale ​ $ 119,154 The following is a summary of income statement information of operations reported as discontinued operations, which includes Adtalem Brazil’s, Carrington’s, and DeVry University’s operations through the date of each respective sale (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Revenue ​ $ — ​ $ 55,153 ​ $ — ​ $ 100,805 ​ Operating cost and expense: ​ ​ ​ ​ ​ ​ ​ ​ ​ Cost of educational services ​ — ​ 35,717 ​ — ​ 69,665 ​ Student services and administrative expense ​ 11,187 ​ 15,706 ​ 21,271 ​ 30,079 ​ Restructuring expense ​ — ​ 391 ​ — ​ 426 ​ Total operating cost and expense ​ 11,187 ​ 51,814 ​ 21,271 ​ 100,170 ​ Operating (loss) income ​ (11,187) ​ 3,339 ​ (21,271) ​ 635 ​ Other income (expense): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest and dividend income ​ ​ — ​ ​ 761 ​ ​ — ​ ​ 1,739 ​ Interest expense ​ ​ — ​ ​ (806) ​ ​ — ​ ​ (1,963) ​ Net other expense ​ — ​ (45) ​ — ​ (224) ​ (Loss) income from discontinued operations before income taxes ​ ​ (11,187) ​ ​ 3,294 ​ ​ (21,271) ​ ​ 411 ​ Benefit from income taxes ​ 2,748 ​ 823 ​ 5,225 ​ 550 ​ Net (loss) income from discontinued operations attributable to Adtalem ​ $ (8,439) ​ $ 4,117 ​ $ (16,046) ​ $ 961 ​

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregate revenue	The following tables disaggregate revenue by source (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2020 ​ ​ Medical and ​ Financial ​ Consolidated Higher education ​ $ 234,144 ​ $ — ​ $ 234,144 Test preparation/certifications ​ ​ — ​ ​ 31,900 ​ ​ 31,900 Conferences/seminars ​ ​ — ​ ​ 8,178 ​ ​ 8,178 Memberships/subscriptions ​ ​ — ​ ​ 7,798 ​ ​ 7,798 Other ​ ​ 252 ​ ​ 839 ​ ​ 1,091 Total $ 234,396 $ 48,715 $ 283,111 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Six Months Ended December 31, 2020 ​ ​ Medical and Financial ​ Consolidated Higher education $ 452,433 $ — $ 452,433 Test preparation/certifications ​ ​ — ​ ​ 59,176 ​ ​ 59,176 Conferences/seminars ​ ​ — ​ ​ 21,547 ​ ​ 21,547 Memberships/subscriptions ​ ​ — ​ ​ 15,793 ​ ​ 15,793 Other ​ ​ 789 ​ ​ 1,614 ​ ​ 2,403 Total $ 453,222 $ 98,130 $ 551,352 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2019 ​ ​ Medical and ​ Financial ​ Consolidated Higher education ​ $ 214,153 ​ $ — ​ $ 214,153 Test preparation/certifications ​ ​ — ​ ​ 26,938 ​ ​ 26,938 Conferences/seminars ​ ​ — ​ ​ 13,742 ​ ​ 13,742 Memberships/subscriptions ​ ​ — ​ ​ 5,055 ​ ​ 5,055 Other ​ ​ 6,027 ​ ​ 257 ​ ​ 6,284 Total $ 220,180 $ 45,992 $ 266,172 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Six Months Ended December 31, 2019 ​ ​ Medical and Financial ​ Consolidated Higher education ​ $ 415,606 $ — $ 415,606 Test preparation/certifications ​ ​ — ​ ​ 51,909 ​ ​ 51,909 Conferences/seminars ​ ​ — ​ ​ 30,814 ​ ​ 30,814 Memberships/subscriptions ​ ​ — ​ ​ 9,922 ​ ​ 9,922 Other ​ ​ 12,061 ​ ​ 473 ​ ​ 12,534 Total $ 427,667 $ 93,118 $ 520,785

Restructuring Charges (Tables)

Restructuring Charges (Tables)	6 Months Ended
	Dec. 31, 2020
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2020 ​ Six Months Ended December 31, 2020 ​ ​ Real Estate ​ Termination ​ Total ​ Real Estate ​ Termination ​ Total Financial Services $ — $ — $ — ​ $ 1,415 $ — $ 1,415 Home Office and Other ​ 1,165 ​ — ​ 1,165 ​ ​ 3,483 ​ 490 ​ 3,973 Total ​ $ 1,165 ​ $ — ​ $ 1,165 ​ $ 4,898 ​ $ 490 ​ $ 5,388 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2019 ​ Six Months Ended December 31, 2019 ​ ​ Real Estate ​ Termination ​ Total ​ Real Estate ​ Termination ​ Total Medical and Healthcare ​ $ 192 ​ $ 225 ​ $ 417 ​ $ 319 ​ $ 225 ​ $ 544 Financial Services ​ 1,172 ​ (35) ​ 1,137 ​ ​ 2,862 ​ 254 ​ 3,116 Home Office and Other ​ 401 ​ — ​ 401 ​ 4,523 ​ 302 ​ 4,825 Total ​ $ 1,765 ​ $ 190 ​ $ 1,955 ​ $ 7,704 ​ $ 781 ​ $ 8,485
Separation and Restructuring Plan Activity	The following table summarizes the separation and restructuring plan activity for the fiscal years 2020 and 2021, for which cash payments are required (in thousands): ​ ​ ​ ​ Liability balance as of June 30, 2019 ​ $ 25,083 ASC 842 (leases) adjustment (1) ​ ​ (25,030) Liability balance as of July 1, 2019 ​ 53 Increase in liability (separation and other charges) ​ 4,955 Reduction in liability (payments and adjustments) ​ (3,573) Liability balance as of June 30, 2020 ​ 1,435 Increase in liability (separation and other charges) ​ 490 Reduction in liability (payments and adjustments) ​ (1,708) Liability balance as of December 31, 2020 ​ $ 217 (1)

Earnings per Share (Tables)

Earnings per Share (Tables)	6 Months Ended
	Dec. 31, 2020
Earnings per Share
Earnings per Share	The following table sets forth the computations of basic and diluted earnings per share and stock awards not included in the computation of diluted earnings per share when their effect is anti-dilutive (in thousands, except per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income (loss) attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 31,754 ​ $ 1,408 ​ $ 59,291 ​ $ 18,925 ​ Discontinued operations ​ ​ (8,439) ​ ​ 4,117 ​ ​ (16,046) ​ ​ 961 ​ Net ​ $ 23,315 ​ $ 5,525 ​ $ 43,245 ​ $ 19,886 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average shares outstanding ​ 51,654 ​ 53,412 ​ 51,809 ​ 54,215 ​ Unvested participating RSUs ​ 597 ​ 478 ​ 549 ​ 476 ​ Weighted-average basic shares outstanding ​ 52,251 ​ 53,890 ​ 52,358 ​ 54,691 ​ Effect of dilutive stock awards ​ 190 ​ 390 ​ 264 ​ 501 ​ Weighted-average diluted shares outstanding ​ 52,441 ​ 54,280 ​ 52,622 ​ 55,192 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Earnings (loss) per share attributable to Adtalem: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 0.61 ​ $ 0.03 ​ $ 1.13 ​ $ 0.35 ​ Discontinued operations ​ $ (0.16) ​ $ 0.08 ​ $ (0.31) ​ $ 0.02 ​ Net ​ $ 0.45 ​ $ 0.10 ​ $ 0.83 ​ $ 0.36 ​ Diluted: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Continuing operations ​ $ 0.61 ​ $ 0.03 ​ $ 1.13 ​ $ 0.34 ​ Discontinued operations ​ $ (0.16) ​ $ 0.08 ​ $ (0.30) ​ $ 0.02 ​ Net ​ $ 0.44 ​ $ 0.10 ​ $ 0.82 ​ $ 0.36 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-average anti-dilutive stock awards ​ ​ 1,168 ​ ​ 1,025 ​ ​ 1,059 ​ ​ 910 ​

Accounts Receivable and Credi_2

Accounts Receivable and Credit Losses (Tables)	6 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Schedule of classification of our accounts receivable	The classification of our accounts receivable balances was as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2020 ​ ​ ​ Gross ​ ​ Allowance ​ ​ Net Trade receivables, current ​ $ 99,811 ​ $ (11,298) ​ $ 88,513 Financing receivables, current ​ ​ 6,830 ​ ​ (4,292) ​ ​ 2,538 Accounts receivable, current ​ $ 106,641 ​ $ (15,590) ​ $ 91,051 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Financing receivables, current ​ $ 6,830 ​ $ (4,292) ​ $ 2,538 Financing receivables, noncurrent ​ ​ 41,165 ​ ​ (13,063) ​ ​ 28,102 Total financing receivables ​ $ 47,995 ​ $ (17,355) ​ $ 30,640
Schedule of credit quality analysis of financing receivable	The credit quality analysis of financing receivables as of December 31, 2020 was as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amortized Cost Basis by Origination Year ​ ​ ​ ​ ​ Prior ​ 2017 ​ 2018 ​ 2019 ​ 2020 ​ 2021 ​ Total 1-30 days past due $ 767 ​ $ 444 $ 589 $ 909 $ 342 $ 23 $ 3,074 31-60 days past due ​ ​ 631 ​ ​ 500 ​ ​ 97 ​ ​ 123 ​ ​ 183 ​ ​ 29 ​ ​ 1,563 61-90 days past due ​ ​ 261 ​ ​ 417 ​ ​ 69 ​ ​ 195 ​ ​ 245 ​ ​ — ​ ​ 1,187 Greater than 90 days past due ​ ​ 7,635 ​ ​ 2,367 ​ ​ 2,200 ​ ​ 1,027 ​ ​ 506 ​ ​ — ​ ​ 13,735 Total past due ​ ​ 9,294 ​ ​ 3,728 ​ ​ 2,955 ​ ​ 2,254 ​ ​ 1,276 ​ ​ 52 ​ ​ 19,559 Current ​ ​ 11,824 ​ ​ 5,389 ​ ​ 3,891 ​ ​ 4,205 ​ ​ 2,271 ​ ​ 856 ​ ​ 28,436 Financing receivables, gross ​ $ 21,118 ​ $ 9,117 ​ $ 6,846 ​ $ 6,459 ​ $ 3,547 ​ $ 908 ​ $ 47,995
Institutional Loan Balances and Related Allowances for Credit Losses	The following table includes our financing receivables credit risk profile disclosures for prior periods before we adopted ASC 326 on July 1, 2020 (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Over ​ ​ ​ ​ ​ ​ ​ Total ​ ​ 1-30 Days ​ 31-60 Days ​ 61-90 Days ​ 90 Days ​ Total ​ ​ ​ Financing ​ ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Past Due ​ Current ​ Receivables Financing receivables: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2020 ​ $ 7,192 ​ $ 1,755 ​ $ 1,547 ​ $ 13,782 ​ $ 24,276 ​ $ 25,749 ​ $ 50,025 December 31, 2019 ​ $ 3,226 ​ $ 1,601 ​ $ 566 ​ $ 13,407 ​ $ 18,800 ​ $ 31,415 ​ $ 50,215
Rollforward of the allowance for credit losses	The following tables provide a rollforward of the allowance for credit losses (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2020 Six Months Ended December 31, 2020 ​ ​ Trade ​ Financing ​ Total Trade ​ Financing ​ Total Beginning balance $ 10,634 ​ $ 16,815 $ 27,449 ​ $ 10,825 ​ $ 15,690 $ 26,515 Write-offs ​ ​ (1,143) ​ ​ (1,597) ​ ​ (2,740) ​ ​ (1,902) ​ ​ (1,853) ​ ​ (3,755) Recoveries ​ ​ 205 ​ ​ 85 ​ ​ 290 ​ ​ 391 ​ ​ 125 ​ ​ 516 Provision for credit losses ​ ​ 1,602 ​ ​ 2,052 ​ ​ 3,654 ​ ​ 1,984 ​ ​ 3,393 ​ ​ 5,377 Ending balance ​ $ 11,298 ​ $ 17,355 ​ $ 28,653 ​ $ 11,298 ​ $ 17,355 ​ $ 28,653 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended December 31, 2019 ​ Six Months Ended December 31, 2019 ​ ​ Trade ​ Financing ​ Total ​ Trade ​ Financing ​ Total Beginning balance $ 9,231 ​ $ 9,578 $ 18,809 ​ $ 8,243 ​ $ 6,289 $ 14,532 Write-offs ​ ​ (1,306) ​ ​ (45) ​ ​ (1,351) ​ ​ (2,904) ​ ​ (71) ​ ​ (2,975) Recoveries ​ ​ 181 ​ ​ 4 ​ ​ 185 ​ ​ 504 ​ ​ 28 ​ ​ 532 Provision for credit losses ​ ​ 1,546 ​ ​ 4,336 ​ ​ 5,882 ​ ​ 3,809 ​ ​ 7,627 ​ ​ 11,436 Ending balance ​ $ 9,652 ​ $ 13,873 ​ $ 23,525 ​ $ 9,652 ​ $ 13,873 ​ $ 23,525

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Dec. 31, 2020
Property, Plant And Equipment [Abstract]
Schedule of Property and equipment, net	Property and equipment, net consisted of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, ​ ​ 2020 ​ 2020 ​ 2019 Land $ 44,229 ​ $ 43,246 $ 41,480 Building ​ ​ 317,064 ​ ​ 313,068 ​ ​ 311,185 Equipment ​ ​ 261,722 ​ ​ 248,359 ​ ​ 239,417 Construction in progress ​ ​ 16,636 ​ ​ 12,449 ​ ​ 12,936 Property and equipment, gross ​ ​ 639,651 ​ ​ 617,122 ​ ​ 605,018 Accumulated depreciation ​ (349,415) ​ (331,020) ​ (323,043) Property and equipment, net ​ $ 290,236 ​ $ 286,102 ​ $ 281,975

Leases (Tables)

Leases (Tables)	6 Months Ended
	Dec. 31, 2020
Lessee Disclosure [Abstract]
Summary of components of lease cost	The components of lease cost were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Operating lease cost ​ $ 13,964 ​ $ 15,305 ​ $ 26,744 ​ $ 29,008 Sublease income ​ (4,035) ​ (5,060) ​ (8,376) ​ (10,186) Total lease cost ​ $ 9,929 ​ $ 10,245 ​ $ 18,368 ​ $ 18,822
Summary of maturities of lease liabilities	Maturities of lease liabilities by fiscal year as of December 31, 2020 were as follows (in thousands): ​ ​ ​ ​ ​ ​ Operating Fiscal Year ​ Leases 2021 (remaining) ​ $ 32,576 2022 ​ ​ 64,076 2023 ​ ​ 54,260 2024 ​ ​ 40,604 2025 ​ ​ 30,818 Thereafter ​ ​ 70,929 Total lease payments ​ 293,263 Less: imputed interest ​ ​ (45,473) Present value of lease liabilities ​ $ 247,790
Summary of lease term and discount rate	​ ​ ​ ​ ​ ​ ​ December 31, ​ ​ 2020 Weighted-average remaining operating lease term (years) ​ ​ 5.8 Weighted-average operating lease discount rate ​ ​ 5.6%
Summary of supplemental disclosures of cash flow information related to leases	Supplemental disclosures of cash flow information related to leases were as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, ​ December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts) ​ $ 11,472 ​ $ 12,055 ​ $ 22,899 ​ $ 24,017 Operating lease assets obtained in exchange for operating lease liabilities ​ $ 18,548 ​ $ 787 ​ $ 45,076 ​ $ 5,655
Schedule of Future minimum lease and sublease rental income	Future minimum lease and sublease rental income under these agreements as of December 31, 2020, were as follows (in thousands): ​ ​ ​ ​ ​ Fiscal Year ​ Amount 2021 (remaining) ​ $ 9,344 2022 ​ ​ 17,311 2023 ​ 16,078 2024 ​ 10,261 2025 ​ 5,121 Thereafter ​ ​ 2,038 Total lease and sublease rental income ​ $ 60,153

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	The table below summarizes goodwill balances by reporting unit (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, Reporting Unit ​ 2020 ​ 2020 ​ 2019 Chamberlain ​ $ 4,716 ​ $ 4,716 ​ $ 4,716 AUC ​ 68,321 ​ 68,321 ​ 68,321 RUSM and RUSVM ​ 237,173 ​ 237,173 ​ 237,173 Financial Services ​ 376,347 ​ 376,004 ​ 376,595 Total ​ $ 686,557 ​ $ 686,214 ​ $ 686,805 The table below summarizes goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, Reportable Segment ​ 2020 ​ 2020 ​ 2019 Medical and Healthcare ​ $ 310,210 ​ $ 310,210 ​ $ 310,210 Financial Services ​ 376,347 ​ 376,004 ​ 376,595 Total ​ $ 686,557 ​ $ 686,214 ​ $ 686,805 The table below summarizes the changes in goodwill balances by reportable segment (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and ​ Financial ​ ​ ​ ​ ​ Healthcare ​ Services ​ Total June 30, 2019 ​ $ 310,210 ​ $ 377,046 ​ $ 687,256 Purchase accounting adjustments ​ — ​ (92) ​ (92) Foreign exchange rate changes ​ — ​ (359) ​ (359) December 31, 2019 ​ ​ 310,210 ​ ​ 376,595 ​ ​ 686,805 Foreign exchange rate changes ​ ​ — ​ ​ (591) ​ ​ (591) June 30, 2020 ​ ​ 310,210 ​ ​ 376,004 ​ ​ 686,214 Foreign exchange rate changes ​ — ​ 343 ​ 343 December 31, 2020 ​ $ 310,210 ​ $ 376,347 ​ $ 686,557
Schedule of Intangible Assets	Intangible assets consisted of the following (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2020 ​ ​ ​ ​ Gross Carrying ​ Accumulated ​ Weighted-Average ​ ​ Amount ​ Amortization ​ Amortization Period Amortizable intangible assets: ​ ​ ​ ​ ​ ​ ​ Customer relationships ​ $ 68,900 ​ $ (24,444) 10 Years Curriculum/software ​ 11,600 ​ (3,061) 6 Years Course delivery technology ​ 6,700 ​ (2,122) 5 Years Total ​ $ 87,200 ​ $ (29,627) ​ Indefinite-lived intangible assets: ​ ​ ​ ​ ​ Trade names ​ $ 95,705 ​ ​ ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ ​ ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ ​ ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ ​ ​ Intellectual property ​ 13,940 ​ ​ ​ Total ​ $ 224,945 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ June 30, 2020 ​ ​ Gross Carrying ​ Accumulated ​ ​ Amount ​ Amortization Amortizable intangible assets: ​ ​ ​ ​ ​ ​ Customer relationships ​ $ 68,900 ​ $ (21,044) Curriculum/software ​ ​ 11,600 ​ ​ (2,094) Course delivery technology ​ ​ 7,200 ​ ​ (1,952) Total ​ $ 87,700 ​ $ (25,090) Indefinite-lived intangible assets: ​ ​ ​ ​ Trade names ​ $ 95,664 ​ ​ Chamberlain Title IV eligibility and accreditations ​ 1,200 ​ ​ AUC Title IV eligibility and accreditations ​ 100,000 ​ ​ Ross Title IV eligibility and accreditations ​ 14,100 ​ ​ Intellectual property ​ 13,940 ​ ​ Total ​ $ 224,904 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2019 ​ ​ Gross Carrying ​ Accumulated ​ ​ Amount ​ Amortization Amortizable intangible assets: ​ ​ ​ ​ Customer relationships ​ $ 68,900 ​ $ (17,591) Curriculum/software ​ ​ 11,600 ​ ​ (1,128) Course delivery technology ​ ​ 7,200 ​ ​ (1,219) Total ​ $ 87,700 ​ $ (19,938) Indefinite-lived intangible assets: ​ ​ ​ ​ ​ ​ Trade names ​ $ 95,734 ​ ​ ​ Chamberlain Title IV eligibility and accreditations ​ ​ 1,200 ​ ​ ​ AUC Title IV eligibility and accreditations ​ ​ 100,000 ​ ​ ​ Ross Title IV eligibility and accreditations ​ ​ 14,100 ​ ​ ​ Intellectual property ​ ​ 13,940 ​ ​ ​ Total ​ $ 224,974 ​ ​ ​
Summary of Indefinite-Lived Intangible Assets Balances by Reporting Segment	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, Reportable Segment ​ 2020 ​ 2020 ​ 2019 Medical and Healthcare ​ $ 137,500 ​ $ 137,500 ​ $ 137,500 Financial Services ​ 87,445 ​ 87,404 ​ 87,474 Total ​ $ 224,945 ​ $ 224,904 ​ $ 224,974
Estimated Amortization Expense for Amortized Intangible Assets	Estimated intangible asset amortization expense is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ Financial ​ Fiscal Year ​ Services ​ 2021 (remaining) ​ $ 5,036 ​ 2022 ​ 9,943 ​ 2023 ​ 9,792 ​ 2024 ​ 9,509 ​ 2025 ​ 7,933 ​ Thereafter ​ 15,360 ​ Total ​ $ 57,573 ​

Debt (Tables)

Debt (Tables)	6 Months Ended
	Dec. 31, 2020
Debt Instruments [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt consisted of the following senior secured credit facility (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, ​ June 30, ​ December 31, ​ ​ 2020 ​ 2020 ​ 2019 Total debt: ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan ​ $ 292,500 ​ $ 294,000 ​ $ 295,500 Revolver ​ — ​ — ​ 125,000 Total principal payments due ​ 292,500 ​ 294,000 ​ 420,500 Deferred debt issuance costs ​ (5,369) ​ (4,885) ​ (5,395) Total amount outstanding ​ 287,131 ​ 289,115 ​ 415,105 Less current portion: ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan ​ (3,000) ​ (3,000) ​ (3,000) Noncurrent portion ​ $ 284,131 ​ $ 286,115 ​ $ 412,105
Schedule of Maturities of Long-term Debt	Scheduled future maturities of long-term debt were as follows (in thousands): ​ ​ ​ ​ ​ ​ Maturity Fiscal Year ​ Payments 2021 (remaining) ​ $ 1,500 2022 ​ 3,000 2023 ​ 3,000 2024 ​ 3,000 2025 ​ 282,000 Total ​ $ 292,500
Schedule Of Debt Issuance Costs	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Term B Loan ​ Revolver ​ Total Deferred debt issuance costs as of June 30, 2020 ​ $ 4,885 ​ $ 1,516 ​ $ 6,401 Deferred debt issuance costs for Credit Agreement ​ 1,015 ​ 707 ​ 1,722 Amortization of deferred debt issuance costs ​ (531) ​ (297) ​ (828) Deferred debt issuance costs as of December 31, 2020 ​ $ 5,369 ​ $ 1,926 ​ $ 7,295

Redeemable Noncontrolling Int_2

Redeemable Noncontrolling Interest (Tables)	6 Months Ended
	Dec. 31, 2020
Noncontrolling Interest [Abstract]
Reconciliation of Non-Controlling Interest Balance	The following is a reconciliation of the redeemable noncontrolling interest balance (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, ​ December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Balance at beginning of period ​ $ 2,761 ​ $ 3,187 ​ $ 2,852 ​ $ 9,543 Net loss attributable to redeemable noncontrolling interest ​ (166) ​ (105) ​ (257) ​ (214) Payment for purchase of redeemable noncontrolling interest of subsidiary ​ ​ — ​ ​ — ​ ​ — ​ ​ (6,247) Balance at end of period ​ $ 2,595 ​ $ 3,082 ​ $ 2,595 ​ $ 3,082

Share Repurchase (Tables)

Share Repurchase (Tables)	6 Months Ended
	Dec. 31, 2020
Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]
Shares Repurchased Under Programs	Adtalem made share repurchases under the current repurchase program as follows (in thousands, except shares and per share data): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ Life-to-Date ​ ​ December 31, ​ December 31, ​ Current Share ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Repurchase Program Total number of share repurchases ​ ​ 1,473,863 ​ ​ 1,755,160 ​ ​ 1,473,863 ​ ​ 2,673,967 ​ ​ 7,857,294 Total cost of share repurchases ​ $ 44,963 ​ $ 59,764 ​ $ 44,963 ​ $ 100,019 ​ $ 299,732 Average price paid per share ​ $ 30.51 ​ $ 34.05 ​ $ 30.51 ​ $ 37.40 ​ $ 38.15

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Dec. 31, 2020
Comprehensive Income, Net Of Tax [Abstract]
Schedule of accumulated other comprehensive income loss	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ December 31, ​ December 31, ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 Foreign currency translation adjustments ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance ​ $ (1,065) ​ $ (176,883) ​ $ (1,383) ​ $ (137,389) Gain (loss) on foreign currency translation ​ ​ 443 ​ ​ 17,624 ​ ​ 761 ​ ​ (21,870) Ending balance ​ $ (622) ​ $ (159,259) ​ $ (622) ​ $ (159,259) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Marketable securities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ 240 ​ $ 190 ​ $ 242 ​ $ 131 Beginning balance, tax effect ​ ​ (58) ​ ​ (46) ​ ​ (59) ​ ​ (32) Beginning balance, net of tax ​ ​ 182 ​ ​ 144 ​ ​ 183 ​ ​ 99 Unrealized gain (loss) on marketable securities ​ ​ 3 ​ ​ (4) ​ ​ 2 ​ ​ 55 Tax effect ​ ​ (1) ​ ​ 1 ​ ​ (1) ​ ​ (13) Ending balance ​ $ 184 ​ $ 141 ​ $ 184 ​ $ 141 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest rate swap ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Beginning balance, gross ​ $ (10,232) ​ $ — ​ $ (10,399) ​ $ — Beginning balance, tax effect ​ ​ 2,503 ​ ​ — ​ ​ 2,544 ​ ​ — Beginning balance, net of tax ​ ​ (7,729) ​ ​ — ​ ​ (7,855) ​ ​ — Unrealized gain on interest rate swap ​ ​ 603 ​ ​ — ​ ​ 770 ​ ​ — Tax effect ​ ​ (147) ​ ​ — ​ ​ (188) ​ ​ — Ending balance ​ $ (7,273) ​ $ — ​ $ (7,273) ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Total ending balance at December 31 ​ $ (7,711) ​ $ (159,118) ​ $ (7,711) ​ $ (159,118)

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Dec. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of options Activity	The following is a summary of options activity for the six months ended December 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ ​ ​ ​ ​ ​ ​ Remaining ​ Aggregate ​ ​ Number of ​ Weighted-Average ​ Contractual Life ​ Intrinsic Value ​ ​ Options ​ Exercise Price ​ (in years) ​ (in thousands) Outstanding as of July 1, 2020 1,439,630 ​ $ 31.95 ​ ​ ​ ​ Granted 281,075 ​ 32.03 ​ ​ ​ ​ Exercised (5,450) ​ ​ 23.30 ​ ​ ​ ​ Forfeited — ​ ​ — ​ ​ ​ ​ Expired (35,050) ​ ​ 41.84 ​ ​ ​ ​ Outstanding as of December 31, 2020 1,680,205 ​ 31.81 6.60 ​ $ 7,686 Exercisable as of December 31, 2020 1,025,387 ​ $ 29.03 5.42 ​ $ 7,137
Fair Values of Stock Option Awards Estimated Weighted Average Assumptions	The fair value of Adtalem’s stock option grants was estimated assuming the following weighted-average assumptions: ​ ​ ​ ​ ​ ​ ​ ​ ​ Fiscal Year ​ ​ 2021 ​ 2020 ​ Expected life (in years) 6.54 6.51 Expected volatility 39.27 % 37.66 % Risk-free interest rate 0.45 % 1.40 % Dividend yield 0.00 % 0.00 %
Summary of Restricted Stock Units Activity	The following is a summary of RSU activity for the six months ended December 31, 2020: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted-Average ​ ​ Number of ​ Grant Date ​ ​ RSUs ​ Fair Value Outstanding as of July 1, 2020 767,973 ​ $ 39.42 Granted 564,900 ​ 30.62 Vested (361,728) ​ 34.92 Forfeited (24,630) ​ 38.88 Outstanding as of December 31, 2020 946,515 ​ $ 35.90
Total Stock-Based Compensation Expense Included in Consolidated Statement of Earnings	The following table shows total stock-based compensation expense included in the Consolidated Statements of Income (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Cost of educational services ​ $ 345 ​ $ 312 ​ $ 738 ​ $ 767 ​ Student services and administrative expense ​ 3,303 ​ 3,012 ​ 6,914 ​ 7,780 ​ ​ ​ 3,648 ​ 3,324 ​ 7,652 ​ 8,547 ​ Income tax benefit ​ (641) ​ (713) ​ (1,167) ​ (3,246) ​ Net stock-based compensation expense ​ $ 3,007 ​ $ 2,611 ​ $ 6,485 ​ $ 5,301 ​

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Tabulation of Business Segment Information Based on Current Segmentation	Summary financial information by reportable segment is as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Revenue: ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 234,396 ​ $ 220,180 ​ $ 453,222 ​ $ 427,667 ​ Financial Services ​ 48,715 ​ 45,992 ​ 98,130 ​ 93,118 ​ Total consolidated revenue ​ $ 283,111 ​ $ 266,172 ​ $ 551,352 ​ $ 520,785 ​ Operating income excluding special items: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 51,290 ​ $ 41,600 ​ $ 104,300 ​ $ 70,227 ​ Financial Services ​ 7,793 ​ 5,679 ​ 16,480 ​ 9,786 ​ Home Office and Other ​ (6,516) ​ (5,013) ​ (13,848) ​ (10,255) ​ Total consolidated operating income excluding special items ​ ​ 52,567 ​ ​ 42,266 ​ ​ 106,932 ​ ​ 69,758 ​ Reconciliation to Consolidated Financial Statements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Restructuring expense ​ (1,165) ​ (1,955) ​ (5,388) ​ (8,485) ​ Business acquisition and integration expense ​ ​ (11,079) ​ — ​ ​ (24,515) ​ — ​ Gain on sale of assets ​ ​ — ​ — ​ ​ — ​ ​ 4,779 ​ Total consolidated operating income ​ ​ 40,323 ​ ​ 40,311 ​ ​ 77,029 ​ ​ 66,052 ​ Net other expense ​ (1,512) ​ (31,438) ​ (3,682) ​ (36,065) ​ Total consolidated income from continuing operations before income taxes ​ $ 38,811 ​ $ 8,873 ​ $ 73,347 ​ $ 29,987 ​ Segment assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 987,276 ​ $ 913,359 ​ $ 987,276 ​ $ 913,359 ​ Financial Services ​ 590,045 ​ 574,813 ​ 590,045 ​ 574,813 ​ Home Office and Other ​ 667,343 ​ 272,601 ​ 667,343 ​ 272,601 ​ Discontinued Operations ​ — ​ 629,837 ​ — ​ 629,837 ​ Total consolidated assets ​ $ 2,244,664 ​ $ 2,390,610 ​ $ 2,244,664 ​ $ 2,390,610 ​ Capital expenditures: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 5,623 ​ $ 6,367 ​ $ 14,889 ​ $ 12,834 ​ Financial Services ​ 2,344 ​ 873 ​ 4,471 ​ 1,412 ​ Home Office and Other ​ 1,765 ​ 2,635 ​ 4,815 ​ 6,065 ​ Total consolidated capital expenditures ​ $ 9,732 ​ $ 9,875 ​ $ 24,175 ​ $ 20,311 ​ Depreciation expense: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Medical and Healthcare ​ $ 7,690 ​ $ 7,540 ​ $ 15,063 ​ $ 14,771 ​ Financial Services ​ 800 ​ 588 ​ 1,529 ​ 882 ​ Home Office and Other ​ 860 ​ 703 ​ 1,733 ​ 1,571 ​ Total consolidated depreciation expense ​ $ 9,350 ​ $ 8,831 ​ $ 18,325 ​ $ 17,224 ​ Intangible asset amortization expense: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Financial Services ​ $ 2,519 ​ $ 2,576 ​ $ 5,037 ​ $ 5,110 ​ Total consolidated intangible asset amortization expense ​ $ 2,519 ​ $ 2,576 ​ $ 5,037 ​ $ 5,110 ​
Revenues and Long-Lived Assets by Geographic Area	Revenue and long-lived assets by geographic area are as follows (in thousands): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Six Months Ended ​ ​ ​ December 31, ​ December 31, ​ ​ ​ 2020 ​ 2019 ​ 2020 ​ 2019 ​ Revenue from unaffiliated customers: ​ ​ ​ ​ ​ ​ ​ ​ ​ Domestic operations ​ $ 176,911 ​ $ 160,410 ​ $ 349,556 ​ $ 312,445 ​ International operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Barbados, St. Kitts, and St. Maarten ​ 92,419 ​ 94,705 ​ 177,480 ​ 185,675 ​ Other ​ 13,781 ​ 11,057 ​ 24,316 ​ 22,665 ​ Total international ​ 106,200 ​ 105,762 ​ 201,796 ​ 208,340 ​ Total consolidated revenue ​ $ 283,111 ​ $ 266,172 ​ $ 551,352 ​ $ 520,785 ​ Long-lived assets: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Domestic operations ​ $ 215,797 ​ $ 200,257 ​ $ 215,797 ​ $ 200,257 ​ International operations: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Barbados, St. Kitts, and St. Maarten ​ 161,825 ​ 162,813 ​ 161,825 ​ 162,813 ​ Other ​ 1,077 ​ 1,755 ​ 1,077 ​ 1,755 ​ Total international ​ 162,902 ​ 164,568 ​ 162,902 ​ 164,568 ​ Total consolidated long-lived assets ​ $ 378,699 ​ $ 364,825 ​ $ 378,699 ​ $ 364,825 ​

Nature of Operations (Details)

Nature of Operations (Details) $ in Millions	Sep. 11, 2020USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2020USD ($)segment
Number of reporting segments | segment			2
Senior Secured Term Loan Facility [Member] | Scenario, Plan [Member]
Debt instrument, face amount	$ 1,000
Senior Secured Revolving Loan Facility [Member] | Scenario, Plan [Member]
Maximum borrowing capacity	400
Senior Secured Notes [Member] | Scenario, Plan [Member]
Debt instrument, face amount	650
Senior Secured Bridge Term Loan Facility [Member] | Scenario, Plan [Member]
Maximum borrowing capacity	650
Walden [Member]
Acquisition and integration costs		$ 11.1	$ 24.5
Walden [Member] | Scenario, Plan [Member]
Cash paid for acquisition	$ 1,480

Discontinued Operations and A_3

Discontinued Operations and Assets Held for Sale (Summary of Balance Sheet Information of Assets and Liabilities) (Detail) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2019	Dec. 31, 2020	Jun. 30, 2020
Current assets:
Cash and cash equivalents	$ 104,040
Accounts receivable, net	60,494
Prepaid expenses and other current assets	6,750
Total current assets held for sale	171,284	$ 0	$ 0
Noncurrent assets:
Property and equipment, net	74,939
Operating lease assets	72,665
Deferred income taxes	5,346
Intangible assets, net	114,296
Goodwill	179,199
Other assets, net	12,108
Total noncurrent assets held for sale	458,553	0	0
Total assets held for sale	629,837
Current liabilities:
Accounts payable	2,936
Accrued payroll and benefits	13,273
Accrued liabilities	6,484
Deferred revenue	3,096
Current operating lease liabilities	10,905
Total current liabilities held for sale	36,694	0	0
Noncurrent liabilities:
Long-term operating lease liabilities	62,345
Deferred income taxes	3,929
Other liabilities	16,186
Total noncurrent liabilities held for sale	82,460	$ 0	$ 0
Total liabilities held for sale	$ 119,154

Discontinued Operations and A_4

Discontinued Operations and Assets Held for Sale (Summary of Income Statement Information of Operations) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Discontinued Operations And Disposal Groups [Abstract]
Revenue	$ 0	$ 55,153	$ 0	$ 100,805
Operating cost and expense:
Cost of educational services	0	35,717	0	69,665
Student services and administrative expense	11,187	15,706	21,271	30,079
Restructuring expense	0	391	0	426
Total operating cost and expense	11,187	51,814	21,271	100,170
Operating (loss) income	(11,187)	3,339	(21,271)	635
Interest and dividend income	0	761	0	1,739
Interest expense	0	(806)	0	(1,963)
Net other expense	0	(45)	0	(224)
(Loss) income from discontinued operations before income taxes	(11,187)	3,294	(21,271)	411
Benefit from income taxes	2,748	823	5,225	550
Net (loss) income from discontinued operations	$ (8,439)	$ 4,117	$ (16,046)	$ 961

Discontinued Operations and A_5

Discontinued Operations and Assets Held for Sale (Additional Information) (Detail) $ in Thousands, R$ in Millions	Apr. 24, 2020USD ($)	Dec. 11, 2018USD ($)	Dec. 11, 2018USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2019USD ($)	Apr. 24, 2020BRL (R$)
Financing receivables, noncurrent - Net				$ 28,102		$ 28,102
Notes, Loans and Financing Receivable, Net, Current, Total				2,538		2,538
Cash balance					$ 104,040		$ 104,040
Gain (Loss) on Derivative Instruments, Net, Pretax				$ 0	(28,006)	$ 0	$ (28,006)
Carrington College [Member] | Discontinued Operations, Disposed of by Sale
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax									$ 11,300
Cash and restricted cash transferred to discontinued operations									(9,900)
DeVry University [Member]
Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax									22,300
Earn Out Term			10 years
Earn Out Maximum			$ 20,000
Receivable with Imputed Interest, Face Amount		$ 10,000	$ 10,000
Receivable with Imputed Interest, Effective Yield (Interest Rate)		4.00%	4.00%
Receivable with Imputed Interest, Due Date		Jan. 1, 2022	Jan. 1, 2022
Operating lease, option to extend						true
Lessee, Operating Lease, Term of Contract				1 year		1 year
Cash and restricted cash transferred to discontinued operations									$ (40,200)
DeVry University [Member] | Prepaid Expenses and Other Current Assets
Notes, Loans and Financing Receivable, Net, Current, Total				$ 5,100		$ 5,100
Adtalem Educational Do Brazil [Member] | Discontinued Operations, Disposed of by Sale
Consideration from disposal | R$										R$ 1920
Proceeds from sale of business, net of cash transferred	$ 313,500
Proceeds From Sales Of Business Sale, Proceeds	345,900
Proceeds From Sales Of Business, Cash	56,000
Proceeds from Sales of Business, Affiliate and Productive Assets	401,900
Cash balance	$ 88,400
Derivative notional amount | R$										R$ 2154
Loss on cash flow hedge					$ 28,000
Derivative, Gain (Loss) on Derivative, Net								$ 110,700
Gain (Loss) on Derivative Instruments, Net, Pretax								$ 110,700

Revenue (Disaggregate revenue)

Revenue (Disaggregate revenue) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Revenue	$ 283,111	$ 266,172	$ 551,352	$ 520,785
Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenue	234,144	214,153	452,433	415,606
Test Preparation/Certifications [Member]
Disaggregation of Revenue [Line Items]
Revenue	31,900	26,938	59,176	51,909
Conferences/Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenue	8,178	13,742	21,547	30,814
Memberships/Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenue	7,798	5,055	15,793	9,922
Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,091	6,284	2,403	12,534
Medical and Healthcare [Member]
Disaggregation of Revenue [Line Items]
Revenue	234,396	220,180	453,222	427,667
Medical and Healthcare [Member] | Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenue	234,144	214,153	452,433	415,606
Medical and Healthcare [Member] | Test Preparation/Certifications [Member]
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Medical and Healthcare [Member] | Conferences/Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Medical and Healthcare [Member] | Memberships/Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Medical and Healthcare [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	252	6,027	789	12,061
Financial Services [Member]
Disaggregation of Revenue [Line Items]
Revenue	48,715	45,992	98,130	93,118
Financial Services [Member] | Higher Education [Member]
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Financial Services [Member] | Test Preparation/Certifications [Member]
Disaggregation of Revenue [Line Items]
Revenue	31,900	26,938	59,176	51,909
Financial Services [Member] | Conferences/Seminars [Member]
Disaggregation of Revenue [Line Items]
Revenue	8,178	13,742	21,547	30,814
Financial Services [Member] | Memberships/Subscriptions [Member]
Disaggregation of Revenue [Line Items]
Revenue	7,798	5,055	15,793	9,922
Financial Services [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 839	$ 257	$ 1,614	$ 473

Revenue (Additional Information

Revenue (Additional Information) (Detail) $ in Millions	1 Months Ended	6 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2020USD ($)
Disaggregation of Revenue [Line Items]
Revenue recognized included in the deferred revenue		$ 84
Early Title I V Funds Received	$ 35.5
Maximum
Disaggregation of Revenue [Line Items]
Revenue practical expedient remaining performance obligation	1 year	1 year

Restructuring Charges (Restruct

Restructuring Charges (Restructuring and Related Costs) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 1,165	$ 1,955	$ 5,388	$ 8,485
Medical and Healthcare [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		417		544
Financial Services [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	1,137	1,415	3,116
Home Office And Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	1,165	401	3,973	4,825
Real Estate and Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	1,165	1,765	4,898	7,704
Real Estate and Other [Member] | Medical and Healthcare [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		192		319
Real Estate and Other [Member] | Financial Services [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	1,172	1,415	2,862
Real Estate and Other [Member] | Home Office And Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	1,165	401	3,483	4,523
Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	190	490	781
Termination Benefits [Member] | Medical and Healthcare [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		225		225
Termination Benefits [Member] | Financial Services [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	(35)	0	254
Termination Benefits [Member] | Home Office And Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 0	$ 0	$ 490	$ 302

Restructuring Charges (Separati

Restructuring Charges (Separation and Restructuring Plan Activity) (Detail) - USD ($) $ in Thousands	Jul. 01, 2019	Dec. 31, 2020	Jun. 30, 2020
Restructuring Cost and Reserve [Line Items]
Liability beginning balance	$ 25,083	$ 1,435	$ 25,083
Increase in liability (separation and other charges)		490	4,955
Reduction in liability (payments and adjustments)		(1,708)	(3,573)
Liability ending balance	53	$ 217	$ 1,435
ASC 842
Restructuring Cost and Reserve [Line Items]
Reduction in liability from ASU implementation	$ (25,030)

Restructuring Charges (Addition

Restructuring Charges (Additional Information) (Detail) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020	Jul. 01, 2019	Jun. 30, 2019
Restructuring Cost and Reserve [Line Items]
Liability balance	$ 217	$ 1,435	$ 53	$ 25,083
Remaining costs expected to be paid period	12 months
Accrued Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Liability balance	$ 200

Income Taxes (Detail)

Income Taxes (Detail) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019USD ($)	Dec. 31, 2020item	Dec. 31, 2019
Income Tax Contingency [Line Items]
Effective Income Tax Rate Reconciliation, Percent	18.60%	85.30%	19.50%	37.60%
Number of operating units benefit from local tax incentives | item			3
U.S. federal corporate tax rate			21.00%	21.00%
Discontinued Operations, Disposed of by Sale | Adtalem Educational Do Brazil [Member]
Income Tax Contingency [Line Items]
Loss on cash flow hedge | $		$ 28

Earnings per Share (Details)

Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Numerator:
Continuing operations	$ 31,754	$ 1,408	$ 59,291	$ 18,925
Discontinued operations	(8,439)	4,117	(16,046)	961
Net income attributable to Adtalem Global Education	$ 23,315	$ 5,525	$ 43,245	$ 19,886
Denominator:
Weighted-average shares outstanding	51,654	53,412	51,809	54,215
Unvested participating RSUs	597	478	549	476
Weighted-average basic shares outstanding	52,251	53,890	52,358	54,691
Effect of dilutive stock awards	190	390	264	501
Weighted-average diluted shares outstanding	52,441	54,280	52,622	55,192
Basic:
Continuing operations	$ 0.61	$ 0.03	$ 1.13	$ 0.35
Discontinued operations	(0.16)	0.08	(0.31)	0.02
Net	0.45	0.10	0.83	0.36
Diluted:
Continuing operations	0.61	0.03	1.13	0.34
Discontinued operations	(0.16)	0.08	(0.30)	0.02
Net	$ 0.44	$ 0.10	$ 0.82	$ 0.36
Weighted Average
Diluted:
Weighted-average anti-dilutive stock awards	1,168	1,025	1,059	910

Accounts Receivable and Credi_3

Accounts Receivable and Credit Losses (Classification of Accounts Receivable) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019
Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]
Trade receivables, current - Gross	$ 99,811
Trade receivables, current - Allowance	(11,298)
Trade receivables, current - Net	88,513
Financing Receivable, after Allowance for Credit Loss, Current [Abstract]
Financing receivables, current - Gross	6,830
Financing receivables, current - Allowance	(4,292)
Financing receivables, current - Net	2,538
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts receivable, current - Gross	106,641
Accounts receivable, current - Allowance	(15,590)
Accounts receivable, current - Net	91,051		$ 87,042	$ 93,394
Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]
Financing receivables, noncurrent - Gross	41,165
Financing receivables, noncurrent - Allowance	(13,063)
Financing receivables, noncurrent - Net	28,102
Financing Receivable, after Allowance for Credit Loss [Abstract]
Total	47,995		50,025	50,215
Total Financing receivables - Allowance	(17,355)	$ (16,815)	$ (15,690)	$ (13,873)	$ (9,578)	$ (6,289)
Total Financing receivables - Net	$ 30,640

Accounts Receivable and Credi_4

Accounts Receivable and Credit Losses (Credit Quality Analysis of Financing Receivable) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Total	$ 47,995	$ 50,025	$ 50,215
Institutional Loans, Past Due		24,276	18,800
Institutional Loans, Current		25,749	31,415
Total Institutional Loans	47,995	50,025	50,215
Financing Receivables 1 To 30 Days Past Due [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	767
2017	444
2018	589
2019	909
2020	342
2021	23
Total	3,074
Institutional Loans, Past Due		7,192	3,226
Total Institutional Loans	3,074
Financing Receivables 31 To 60Days Past Due [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	631
2017	500
2018	97
2019	123
2020	183
2021	29
Total	1,563
Institutional Loans, Past Due		1,755	1,601
Total Institutional Loans	1,563
Financing Receivables 61 To 90 Days Past Due [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	261
2017	417
2018	69
2019	195
2020	245
2021	0
Total	1,187
Institutional Loans, Past Due		1,547	566
Total Institutional Loans	1,187
Financing Receivables Greater Than 90 Days Past Due [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	7,635
2017	2,367
2018	2,200
2019	1,027
2020	506
2021	0
Total	13,735
Institutional Loans, Past Due		$ 13,782	$ 13,407
Total Institutional Loans	13,735
Financing Receivable Past Due [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	9,294
2017	3,728
2018	2,955
2019	2,254
2020	1,276
2021	52
Total	19,559
Total Institutional Loans	19,559
Financing Receivable Current [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	11,824
2017	5,389
2018	3,891
2019	4,205
2020	2,271
2021	856
Total	28,436
Total Institutional Loans	28,436
Financing Receivable Gross [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Prior	21,118
2017	9,117
2018	6,846
2019	6,459
2020	3,547
2021	908
Total	47,995
Total Institutional Loans	$ 47,995

Accounts Receivable and Credi_5

Accounts Receivable and Credit Losses (Financing Receivables Past Due Prior to Adopting ASC 326) (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due		$ 24,276	$ 18,800
Institutional Loans, Current		25,749	31,415
Total Institutional Loans	$ 47,995	50,025	50,215
Financing Receivables 1 To 30 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due		7,192	3,226
Total Institutional Loans	3,074
Financing Receivables 31 To 60Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due		1,755	1,601
Total Institutional Loans	1,563
Financing Receivables 61 To 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due		1,547	566
Total Institutional Loans	1,187
Financing Receivables Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Institutional Loans, Past Due		$ 13,782	$ 13,407
Total Institutional Loans	$ 13,735

Accounts Receivable and Credi_6

Accounts Receivable and Credit Losses (Rollforward of Allowances for Credit Losses) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Trade
Beginning balance	$ 10,634	$ 9,231	$ 10,825	$ 8,243
Write-offs	(1,143)	(1,306)	(1,902)	(2,904)
Recoveries	205	181	391	504
Provision for credit losses	1,602	1,546	1,984	3,809
Ending balance	11,298	9,652	11,298	9,652
Financing
Beginning balance	16,815	9,578	15,690	6,289
Write-offs	(1,597)	(45)	(1,853)	(71)
Recoveries	85	4	125	28
Provision for credit losses	2,052	4,336	3,393	7,627
Ending balance	17,355	13,873	17,355	13,873
Allowance for credit losses
Beginning balance	27,449	18,809	26,515	14,532
Write-offs	(2,740)	(1,351)	(3,755)	(2,975)
Recoveries	290	185	516	532
Provision for credit losses	3,654	5,882	5,377	11,436
Ending balance	$ 28,653	$ 23,525	$ 28,653	$ 23,525

Accounts Receivable and Credi_7

Accounts Receivable and Credit Losses (Additional Information) (Detail) - USD ($) $ in Thousands	Jul. 31, 2019	Dec. 11, 2018	Dec. 11, 2018	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Jun. 30, 2019
Financing Receivables [Line Items]
Net Institutional Student Loans, Current				$ 2,538
Net Institutional Student Loans, Noncurrent				28,102
Financing Receivable Allowance For Credit Losses				$ 17,355	$ 13,873	$ 16,815	$ 15,690	$ 9,578	$ 6,289
Minimum
Financing Receivables [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)				3.00%
Maximum
Financing Receivables [Line Items]
Receivable with Imputed Interest, Effective Yield (Interest Rate)				12.00%
DeVry University [Member]
Financing Receivables [Line Items]
Financing Receivable Allowance For Credit Losses				$ 0
Receivable with Imputed Interest, Face Amount		$ 10,000	$ 10,000
Receivable with Imputed Interest, Effective Yield (Interest Rate)		4.00%	4.00%
Receivable with Imputed Interest, Due Date		Jan. 1, 2022	Jan. 1, 2022
Future Cash Flows Discounting Rate				4.00%
DeVry University [Member] | Other Noncurrent Assets [Member]
Financing Receivables [Line Items]
Loan Receivable				$ 10,000	10,000		10,000
DeVry University [Member] | Prepaid Expenses and Other Current Assets
Financing Receivables [Line Items]
Net Institutional Student Loans, Current				5,100
Loan Receivable				5,100
Chicago, Illinois Campus [Member] | Other Noncurrent Assets [Member]
Financing Receivables [Line Items]
Loan Receivable				42,000	40,800		41,400
Chicago, Illinois Campus [Member] | Discontinued Operations, Disposed of by Sale
Financing Receivables [Line Items]
Financing Receivable Allowance For Credit Losses				0
Receivable with Imputed Interest, Face Amount	$ 46,800
Receivable with Imputed Interest, Effective Yield (Interest Rate)	4.00%
Receivable with Imputed Interest, Due Date	Jul. 31, 2024
Loan Receivable				$ 42,000	$ 40,800		$ 41,400
Future Cash Flows Discounting Rate					7.00%

Property and Equipment, Net (Sc

Property and Equipment, Net (Schedule of Property and equipment, net) (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Property and Equipment, Net
Property and equipment, gross	$ 639,651	$ 617,122	$ 605,018
Accumulated depreciation	(349,415)	(331,020)	(323,043)
Property and equipment, net	290,236	286,102	281,975
Land [Member]
Property and Equipment, Net
Property and equipment, gross	44,229	43,246	41,480
Building [Member]
Property and Equipment, Net
Property and equipment, gross	317,064	313,068	311,185
Equipment [Member]
Property and Equipment, Net
Property and equipment, gross	261,722	248,359	239,417
Construction in progress [Member]
Property and Equipment, Net
Property and equipment, gross	$ 16,636	$ 12,449	$ 12,936

Property and Equipment, Net (Ad

Property and Equipment, Net (Additional Information) (Details) - USD ($) $ in Thousands	Sep. 27, 2019	Jul. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Real Estate [Line Items]
Depreciation expense			$ 9,350	$ 8,831		$ 18,325	$ 17,224
Property and equipment, net			290,236	281,975		290,236	281,975	$ 286,102
Proceeds From Down Payment On Seller Loan						0	5,200
Notes receivable				60,494			60,494
Financing payables				16,186			16,186
Proceeds from Sales of Assets, Investing Activities						0	6,421
Realized Gain on Sale of Assets			$ 0	$ 0		$ 0	$ 4,779
Discontinued Operations, Disposed of by Sale | Chicago, Illinois Campus [Member]
Real Estate [Line Items]
Proceeds from disposal		$ 52,000
Proceeds From Down Payment On Seller Loan		5,200			$ 5,200
Receivable with Imputed Interest, Face Amount		$ 46,800
Receivable with Imputed Interest, Effective Yield (Interest Rate)		4.00%
Discontinued Operations, Disposed of by Sale | Chicago, Illinois Campus [Member] | Other Noncurrent Assets [Member]
Real Estate [Line Items]
Notes receivable		$ 40,300
Discontinued Operations, Disposed of by Sale | Chicago, Illinois Campus [Member] | Other Liabilities
Real Estate [Line Items]
Financing payables		$ 45,500
Discontinued Operations, Disposed of by Sale | Columbus, Ohio Campus
Real Estate [Line Items]
Proceeds from Sales of Assets, Investing Activities	$ 6,400
Discontinued Operations, Held-for-sale [Member] | Columbus, Ohio Campus
Real Estate [Line Items]
Realized Gain on Sale of Assets	$ 4,800

Leases (Components of Lease Cos

Leases (Components of Lease Cost) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Lease, Cost [Abstract]
Operating Lease Cost	$ 13,964	$ 15,305	$ 26,744	$ 29,008
Sublease Income	(4,035)	(5,060)	(8,376)	(10,186)
Total Lease Cost	$ 9,929	$ 10,245	$ 18,368	$ 18,822

Leases (Maturities of Lease Lia

Leases (Maturities of Lease Liabilities) (Detail) $ in Thousands	Dec. 31, 2020USD ($)
Maturities of lease liabilities
2021 (Remaining)	$ 32,576
2022	64,076
2023	54,260
2024	40,604
2025	30,818
Thereafter	70,929
Total lease payments	293,263
Less: imputed interest	(45,473)
Present value of lease liabilities	$ 247,790

Leases (Lease Term, Discount Ra

Leases (Lease Term, Discount Rate and Cash Flow Information ) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Lessee Disclosure [Abstract]
Weighted-average remaining operating lease term (years)	5 years 9 months 18 days		5 years 9 months 18 days
Weighted-average operating lease discount rate	5.60%		5.60%
Cash paid for amounts in the measurement of operating lease liabilities (net of sublease receipts)	$ 11,472	$ 12,055	$ 22,899	$ 24,017
Operating lease assets obtained in exchange for operating lease liabilities	$ 18,548	$ 787	$ 45,076	$ 5,655

Leases (Future Minimum Rental C

Leases (Future Minimum Rental Commitments for Noncancelable Operating Leases ) (Detail) $ in Thousands	Dec. 31, 2020USD ($)
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]
2021 (Remaining)	$ 9,344
2022	17,311
2023	16,078
2024	10,261
2025	5,121
Thereafter	2,038
Total	$ 60,153

Leases (Additional Information)

Leases (Additional Information) (Detail) $ in Thousands	6 Months Ended
	Dec. 31, 2020USD ($)locationfacilityitem	Sep. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Lessee, Lease, Description [Line Items]
Option to terminate lease	true
Option to extend lease	true
Extension term	5 years
Number of facilities owned by lessor | facility	3
Number of operating lease locations the entity has agreements to sublease either a portion or the full leased space | location	20
Number of leases yet to commence | item	1
Operating Lease, Right-of-Use Asset	$ 192,954		$ 174,935	$ 187,520
Operating Lease, Liability	$ 247,790
Operating Lease, Lease Not yet Commenced, Contract One [Member] | Forecast [Member]
Lessee, Lease, Description [Line Items]
Lease term on property lease that has not yet commenced		11 years
Operating Lease, Right-of-Use Asset		$ 21,300
Operating Lease, Liability		$ 21,300

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Summary of Goodwill Balances by Reporting Unit) (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 686,557	$ 686,214	$ 686,805
Chamberlain University [Member]
Goodwill [Line Items]
Goodwill	4,716	4,716	4,716
AUC [Member]
Goodwill [Line Items]
Goodwill	68,321	68,321	68,321
RUSM and RUSVM [Member]
Goodwill [Line Items]
Goodwill	237,173	237,173	237,173
Financial Services [Member]
Goodwill [Line Items]
Goodwill	$ 376,347	$ 376,004	$ 376,595

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Summary of Goodwill Balances by Reporting Segment) (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill	$ 686,557	$ 686,214	$ 686,805
Medical and Healthcare [Member]
Goodwill [Line Items]
Goodwill	310,210	310,210	310,210
Financial Services [Member]
Goodwill [Line Items]
Goodwill	$ 376,347	$ 376,004	$ 376,595

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill, by Segment) (Detail) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Goodwill [Line Items]
Goodwill beginning balance	$ 686,214	$ 686,805	$ 687,256
Purchase Accounting Adjustments			(92)
Foreign exchange rate changes	343	(591)	(359)
Goodwill ending balance	686,557	686,214	686,805
Medical and Healthcare [Member]
Goodwill [Line Items]
Goodwill beginning balance	310,210	310,210	310,210
Purchase Accounting Adjustments			0
Foreign exchange rate changes	0	0	0
Goodwill ending balance	310,210	310,210	310,210
Financial Services [Member]
Goodwill [Line Items]
Goodwill beginning balance	376,004	376,595	377,046
Purchase Accounting Adjustments			(92)
Foreign exchange rate changes	343	(591)	(359)
Goodwill ending balance	$ 376,347	$ 376,004	$ 376,595

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Schedule of Intangible Assets) (Detail) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	$ 87,200	$ 87,700	$ 87,700
Amortizable Intangible Assets, Accumulated Amortization	(29,627)	(25,090)	(19,938)
Indefinite-lived Intangible Assets, Gross Carrying Amount	224,945	224,904	224,974
Customer Relationships [Member]
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	68,900	68,900	68,900
Amortizable Intangible Assets, Accumulated Amortization	$ (24,444)	(21,044)	(17,591)
Amortizable Intangible Assets, Weighted Average Amortization Period	10 years
Curriculum/Software [Member]
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	$ 11,600	11,600	11,600
Amortizable Intangible Assets, Accumulated Amortization	$ (3,061)	(2,094)	(1,128)
Amortizable Intangible Assets, Weighted Average Amortization Period	6 years
Course Delivery Technology
Intangible Assets [Line Items]
Amortizable Intangible Assets, Gross Carrying Amount	$ 6,700	7,200	7,200
Amortizable Intangible Assets, Accumulated Amortization	$ (2,122)	(1,952)	(1,219)
Amortizable Intangible Assets, Weighted Average Amortization Period	5 years
Trade Names [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	$ 95,705	95,664	95,734
Chamberlain Title IV Eligibility And Accreditations [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	1,200	1,200	1,200
AUC Title IV Eligibility And Accreditations [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	100,000	100,000	100,000
Ross Title IV Eligibility And Accreditations [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	14,100	14,100	14,100
Intellectual Property [Member]
Intangible Assets [Line Items]
Indefinite-lived Intangible Assets, Gross Carrying Amount	$ 13,940	$ 13,940	$ 13,940

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets (Summary of Indefinite-Lived Intangible Assets Balances by Reporting Segment) (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets balances	$ 224,945	$ 224,904	$ 224,974
Medical and Healthcare [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets balances	137,500	137,500	137,500
Financial Services [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets balances	$ 87,445	$ 87,404	$ 87,474

Goodwill and Intangible Asset_7

Goodwill and Intangible Assets (Estimated Amortization Expense for Amortized Intangible Assets) (Detail) - Financial Services [Member] $ in Thousands	Dec. 31, 2020USD ($)
Intangible Assets [Line Items]
2021 (remaining)	$ 5,036
2022	9,943
2023	9,792
2024	9,509
2025	7,933
Thereafter	15,360
Total	$ 57,573

Goodwill and Intangible Asset_8

Goodwill and Intangible Assets (Additional Information) (Detail) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020USD ($)segment	Dec. 31, 2019USD ($)	Jun. 30, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Number of reporting units | segment			4
Amortization of Intangible Assets	$ 2,519	$ 2,576	$ 5,037	$ 5,110
Goodwill write-off					$ 0

Debt (Long-term debt) (Detail)

Debt (Long-term debt) (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Total Debt:
Long-term Debt, Gross	$ 292,500	$ 294,000	$ 420,500
Deferred Debt Issuance Costs	(7,295)	(6,401)
Total Amount Outstanding	287,131	289,115	415,105
Less Current Portion:
Term B Loan	(3,000)	(3,000)	(3,000)
Noncurrent Portion	284,131	286,115	412,105
Revolver [Member]
Total Debt:
Long-term Debt, Gross	0	0	125,000
Term Loan [Member]
Total Debt:
Long-term Debt, Gross	292,500	294,000	295,500
Deferred Debt Issuance Costs	$ (5,369)	$ (4,885)	$ (5,395)

Debt (Scheduled maturities of l

Debt (Scheduled maturities of long-term debt) (Detail) - USD ($) $ in Thousands	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
2021 (remaining)	$ 1,500
2022	3,000
2023	3,000
2024	3,000
2025	282,000
Long-term Debt	$ 292,500	$ 294,000	$ 420,500

Debt (Debt Issuance Costs) (Det

Debt (Debt Issuance Costs) (Detail) $ in Thousands	6 Months Ended
	Dec. 31, 2020USD ($)
Deferred Debt Issuance Costs at June 30, 2020	$ 6,401
Deferred Debt Issuance Costs For Credit Agreement	1,722
Amortization of Deferred Debt Issuance Costs	(828)
Deferred debt issuance costs as of September 30, 2020	7,295
Term B Loan [Member]
Deferred Debt Issuance Costs at June 30, 2020	4,885
Deferred Debt Issuance Costs For Credit Agreement	1,015
Amortization of Deferred Debt Issuance Costs	(531)
Deferred debt issuance costs as of September 30, 2020	5,369
Revolver [Member]
Deferred Debt Issuance Costs at June 30, 2020	1,516
Deferred Debt Issuance Costs For Credit Agreement	707
Amortization of Deferred Debt Issuance Costs	(297)
Deferred debt issuance costs as of September 30, 2020	$ 1,926

Debt (Additional Information) (

Debt (Additional Information) (Detail) - USD ($)	Mar. 24, 2020	Apr. 13, 2018	Dec. 31, 2016	Dec. 31, 2020	Dec. 04, 2020	Jun. 30, 2020	Dec. 31, 2019
Line of Credit Facility [Line Items]
Letters of credit outstanding			$ 68,400,000	$ 68,400,000		$ 68,400,000	$ 68,400,000
Letter Of Credit Title Iv Disbursement Percentage			10.00%
Letter of credit, repayment period			5 years
Commitment fee percentage				0.40%
Credit annual fee percentage reimbursement				2.00%
Annual fee percentage				2.25%
Line of Credit facility, initiation date		Apr. 13, 2018
Outstanding letters of credit				$ 231,600,000
Long-term debt				287,131,000		289,115,000	415,105,000
Increase in line of credit facility		$ 250,000,000
Debt issuance costs, gross		$ 9,900,000			$ 1,700,000
Long-term debt, gross				$ 292,500,000		$ 294,000,000	$ 420,500,000
Scenario, Plan [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Unused Borrowing Capacity, Amount					1,000,000,000
Term Loan [Member]
Line of Credit Facility [Line Items]
Interest rate for borrowings under the Term B Loan facility				3.15%		3.18%	4.80%
Debt instrument, maturity date		Apr. 13, 2025
Debt instrument, face amount		$ 300,000,000
Principal payment		750,000
Debt issuance costs, gross		$ 7,100,000			1,000,000
Amortization period		7 years
Debt covenant reinvested term				1 year
Eurocurrency Rate [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Debt instrument, description of variable rate basis				LIBOR-equivalent rate plus 3%
Basic spread rate	3.00%			3.00%
Base Rate [Member] | Term Loan [Member]
Line of Credit Facility [Line Items]
Debt instrument, description of variable rate basis				base rate plus 2%
Basic spread rate				2.00%
Revolver [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 300,000,000
Line of credit facility, expiration date		Apr. 13, 2023
Foreign currency borrowing capacity		$ 200,000,000
Long-term Line of Credit				$ 0		$ 0	$ 125,000,000
Debt issuance costs, gross		$ 2,700,000			$ 700,000
Amortization period		5 years
Revolver [Member] | Minimum
Line of Credit Facility [Line Items]
Application rate, percentage				1.75%
Revolver [Member] | Maximum
Line of Credit Facility [Line Items]
Application rate, percentage				2.75%
Revolver [Member] | Weighted Average
Line of Credit Facility [Line Items]
Application rate, percentage							3.87%
Revolver [Member] | Prime Rate [Member] | Minimum
Line of Credit Facility [Line Items]
Application rate, percentage				0.75%
Revolver [Member] | Prime Rate [Member] | Maximum
Line of Credit Facility [Line Items]
Application rate, percentage				1.75%
Letter of Credit [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity		$ 100,000,000
Term B Loan [Member]
Line of Credit Facility [Line Items]
Debt Covenant, Mandatory Cash Payment In Excess Of Amount Minimum				$ 50,000,000
Interest Rate Swap | Term Loan [Member]
Line of Credit Facility [Line Items]
Derivative, Fixed Interest Rate	0.946%
Derivative, Swaption Interest Rate				3.946%
Interest Rate Swap | LIBOR | Term Loan [Member]
Line of Credit Facility [Line Items]
Debt instrument, description of variable rate basis	one-month LIBOR
Interest Rate Swap | LIBOR | Minimum | Term Loan [Member]
Line of Credit Facility [Line Items]
Derivative, Floor Interest Rate	0.00%

Redeemable Noncontrolling Int_3

Redeemable Noncontrolling Interest (Reconciliation of Non-Controlling Interest Balance) (Detail) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019
Noncontrolling Interest [Abstract]
Balance at Beginning of Period	$ 2,761	$ 3,187	$ 9,543	$ 2,852	$ 9,543
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	(166)	(105)		(257)	(214)
Payment for purchase of redeemable noncontrolling interest of subsidiary	0	0		0	(6,247)
Balance at End of Period	$ 2,595	$ 3,082	$ 3,187	$ 2,595	$ 3,082

Redeemable Noncontrolling Int_4

Redeemable Noncontrolling Interest (Additional Information) (Detail) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Mar. 26, 2020	Jul. 01, 2019	Jun. 30, 2019
Noncontrolling Interest [Line Items]
Decrease in noncontrolling interest	$ 0	$ 0		$ 0	$ 6,247
Adtalem Brazil [Member]
Noncontrolling Interest [Line Items]
Ownership interest of parent in subsidiary							100.00%	97.90%
Decrease in noncontrolling interest			$ 6,200
Edupristine [Member]
Noncontrolling Interest [Line Items]
Ownership interest of parent in subsidiary	71.00%			71.00%
Ownership percentage held by minority available for purchase						33.00%
Adtalem Brazil Senior Management Group [Member] | Adtalem Brazil [Member]
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners								2.10%
Kaizen [Member] | Edupristine [Member]
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	29.00%			29.00%

Share Repurchase (Detail)

Share Repurchase (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Feb. 04, 2020	Nov. 08, 2018
Equity, Class of Treasury Stock [Line Items]
Total number of share repurchases	1,473,863	1,755,160	1,473,863	2,673,967
Total cost of share repurchases	$ 44,963	$ 59,764	$ 44,963	$ 100,019
Average price paid per share	$ 30.51	$ 34.05	$ 30.51	$ 37.40
Life-to-Date Current Shares Repurchase Program Total number of share repurchases	7,857,294		7,857,294
Life-to-Date Current Shares Repurchase Program Total cost of share repurchases	$ 299,732		$ 299,732
Life-to-Date Current Shares Repurchase Program Average price paid per share	$ 38.15		$ 38.15
Authorized On February Fourth Two-Thousand Twenty [Member]
Equity, Class of Treasury Stock [Line Items]
Authorized amount for repurchase					$ 300,000
Maximum
Equity, Class of Treasury Stock [Line Items]
Remaining authorized amount for repurchase	$ 300,300		$ 300,300
Maximum | Authorized On November Eighth Two-Thousand Twenty [Member]
Equity, Class of Treasury Stock [Line Items]
Authorized amount for repurchase						$ 300,000

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Net of Tax	$ 1,330,971	$ 1,327,193	$ 1,310,421	$ 1,391,530
Retained earnings	1,970,813	2,032,788	1,970,813	2,032,788	$ 1,927,568
Balance at the end of period - Net of Tax	1,313,779	1,294,912	1,313,779	1,294,912
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Net of Tax	(8,612)	(176,739)	(9,055)	(137,290)
Balance at the end of period - Net of Tax	(7,711)	(159,118)	(7,711)	(159,118)
Foreign currency translation adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Net of Tax	(1,065)	(176,883)	(1,383)	(137,389)
Other comprehensive income (loss) - Gross	443	17,624	761	(21,870)
Balance at the end of period - Net of Tax	(622)	(159,259)	(622)	(159,259)
Marketable Securities.
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Gross	240	190	242	131
Balance at the beginning of period - Tax	58	46	59	32
Balance at the beginning of period - Net of Tax	182	144	183	99
Other comprehensive income (loss) - Gross	3	(4)	2	55
Other comprehensive income (loss) - Tax	(1)	1	(1)	(13)
Balance at the end of period - Net of Tax	184	141	184	141
Interest Rate Swap
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at the beginning of period - Gross	(10,232)	0	(10,399)	0
Balance at the beginning of period - Tax	(2,503)	0	(2,544)	0
Balance at the beginning of period - Net of Tax	(7,729)	0	(7,855)	0
Other comprehensive income (loss) - Gross	603	0	770	0
Other comprehensive income (loss) - Tax	(147)	0	(188)	0
Balance at the end of period - Net of Tax	$ (7,273)	$ 0	$ (7,273)	$ 0

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary of Options Activity) (Detail) - Stock Option $ / shares in Units, $ in Thousands	6 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Number of Options, Outstanding at beginning of period | shares	1,439,630
Number of Options, Granted | shares	281,075
Number of Options, Exercised | shares	(5,450)
Number of Options Forfeited | shares	0
Number of Options Expired | shares	(35,050)
Number of Options, Outstanding at end of period | shares	1,680,205
Number of Options, Exercisable at end of period | shares	1,025,387
Weighted Average Exercise Price at beginning of period | $ / shares	$ 31.95
Weighted Average Exercise Price, Options Granted | $ / shares	32.03
Weighted Average Exercise Price, Options Exercised | $ / shares	23.30
Weighted Average Exercise Price, Options Forfeited | $ / shares	0
Weighted Average Exercise Price, Options Expired | $ / shares	41.84
Weighted Average Exercise Price, Outstanding at end of period | $ / shares	31.81
Weighted Average Exercise Price, Exercisable at end of period | $ / shares	$ 29.03
Weighted Average Remaining Contractual Life, Outstanding at end of period	6 years 7 months 6 days
Weighted Average Remaining Contractual Life, Exercisable at end of period	5 years 5 months 1 day
Aggregate Intrinsic Value, Outstanding at End of period | $	$ 7,686
Aggregate Intrinsic Value, Exercisable at end of period | $	$ 7,137

Stock-Based Compensation (Fair

Stock-Based Compensation (Fair Values of Stock Option Awards Weighted Average Assumptions) (Detail)	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected Life (in Years)	6 years 6 months 14 days	6 years 6 months 3 days
Expected Volatility	39.27%	37.66%
Risk-free Interest Rate	0.45%	1.40%
Dividend Yield	0.00%	0.00%

Stock-Based Compensation (Sum_2

Stock-Based Compensation (Summary of Restricted Stock Units Activity) (Detail) - Restricted Stock Units - $ / shares	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Outstanding at beginning of period	767,973
Restricted Stock Units Outstanding, Shares Granted	564,900
Restricted Stock Units Outstanding, Shares Vested	(361,728)
Restricted Stock Units Outstanding, Shares Forfeited	(24,630)
Restricted Stock Units Outstanding at end of period	946,515
Weighted Average Grant Date Fair Value, Nonvested beginning balance	$ 39.42
Weighted Average Grant Date Fair Value, Shares Granted	30.62	$ 42.66
Weighted Average Grant Date Fair Value, Shares Vested	34.92
Weighted Average Grant Date Fair Value, Shares Forfeited	38.88
Weighted Average Grant Date Fair Value, Nonvested ending balance	$ 35.90

Stock-Based Compensation (Total

Stock-Based Compensation (Total Stock-Based Compensation Expense Included in Consolidated Statement of Income) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	$ 3,648	$ 3,324	$ 7,652	$ 8,547
Income Tax Benefit	(641)	(713)	(1,167)	(3,246)
Net Stock-Based Compensation Expense	3,007	2,611	6,485	5,301
Cost of Educational Services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	345	312	738	767
Student Services And Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	$ 3,303	$ 3,012	$ 6,914	$ 7,780

Stock-Based Compensation (Addit

Stock-Based Compensation (Additional Information) (Detail)	6 Months Ended		12 Months Ended
	Dec. 31, 2020USD ($)item$ / sharesshares	Dec. 31, 2019USD ($)$ / shares	Jun. 30, 2020USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total intrinsic value of options exercised | $	$ 100,000	$ 900,000
Total pre-tax unrecognized compensation costs related to non-vested awards | $	$ 29,600,000
Total pre-tax unrecognized compensation costs related to non-vested awards expected to be recognized, years	2 years 7 months 6 days
Total fair value of options and Restricted Stock Units vested | $	$ 16,900,000	13,300,000
Share-based Payment Arrangement, Amount Capitalized | $	$ 0	$ 0	$ 0
Stock Incentive Plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangements plans | item	2
Weighted average estimated grant date fair values, for options granted at market price, per share | $ / shares	$ 12.23	$ 16.98
Common Stock, Capital Shares Reserved for Future Issuance | shares	3,587,986
Stock Incentive Plans | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	10 years
Vesting Period (in years)	5 years
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares	$ 30.62	$ 42.66
Restricted Stock Units Outstanding, Shares Granted | shares	564,900
Performance Based Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	3 years
Restricted Stock Units Outstanding, Shares Granted | shares	191,850
Non-Performance Based Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	3 years
Restricted Stock Units Outstanding, Shares Granted | shares	373,050
Non-Performance Based Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	1 year
Non-Performance Based Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of options (in years)	4 years

Fair Value Measurements (Detail

Fair Value Measurements (Details) $ in Thousands, R$ in Millions	Jul. 31, 2019USD ($)	Dec. 11, 2018USD ($)	Dec. 11, 2018USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2020USD ($)	Jun. 30, 2020USD ($)	Apr. 24, 2020BRL (R$)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt, gross				$ 420,500	$ 292,500	$ 294,000
Accounts Receivable | Credit extension program
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure				36,300	$ 30,600	34,300
DeVry University [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Receivable with Imputed Interest, Face Amount		$ 10,000	$ 10,000
Receivable with Imputed Interest, Effective Yield (Interest Rate)		4.00%	4.00%
Receivable with Imputed Interest, Due Date		Jan. 1, 2022	Jan. 1, 2022
DeVry University [Member] | Discount rate | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument, Measurement Input					0.04
DeVry University [Member] | Prepaid Expenses and Other Current Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure					$ 5,100
Chicago, Illinois Campus [Member] | Discontinued Operations, Disposed of by Sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure				40,800	$ 42,000	41,400
Receivable with Imputed Interest, Face Amount	$ 46,800
Receivable with Imputed Interest, Effective Yield (Interest Rate)	4.00%
Receivable with Imputed Interest, Due Date	Jul. 31, 2024
Chicago, Illinois Campus [Member] | Discount rate | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt Instrument, Measurement Input					0.07
Adtalem Educational Do Brazil [Member] | Discontinued Operations, Disposed of by Sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative notional amount | R$							R$ 2154
Loss on cash flow hedge				$ 28,000
Interest Rate Swap | Other Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset					$ 9,600	$ 10,400

Commitments and Contingencies (

Commitments and Contingencies (Detail)

Jul. 16, 2019individual

May 23, 2019individual

Apr. 04, 2019individual

Jan. 02, 2019individualitem

Jun. 27, 2018individual

Jun. 21, 2018lawsuit

Apr. 13, 2018class

Jan. 25, 2018individual

Jan. 31, 2021plaintiff

Jan. 19, 2021plaintiff

Dec. 31, 2020USD ($)plaintiff

Dec. 09, 2020plaintiff

Oct. 14, 2020plaintiff

Jun. 30, 2020USD ($)

Feb. 07, 2020lawsuit

Jun. 07, 2019plaintiff

Dec. 10, 2018lawsuit

May 08, 2018plaintiff

Loss Contingencies [Line Items]

Number of lawsuits | lawsuit

2

Nicole Versetto [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | class

3

Loss contingency accrual | $

$ 44,950,000

Nicole Versetto [Member] | Prepaid Expenses and Other Current Assets

Loss Contingencies [Line Items]

Settlement fund | $

$ 44,950,000

$ 44,950,000

Carlson Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | individual

13

32

71

Number of groups plaintiffs motions to dismiss | item

3

Number of plaintiffs dismissed

2

3

6

Number of plaintiffs, added

12

2

Number of Plaintiffs

109

Lawsuit In United States District Court for the Western District of Texas

Loss Contingencies [Line Items]

Number of plaintiffs dismissed

107

Number of plaintiffs, unsettled

2

1

Number of Plaintiffs

109

Number Of Plaintiffs, Agreed To Settle

1

Lawsuit In United States District Court for the Northern District of California

Loss Contingencies [Line Items]

Number of plaintiffs dismissed

108

Number of plaintiffs, unsettled

3

Number of Plaintiffs

112

Number Of Plaintiffs, Agreed To Settle

1

Number of plaintiffs, council moved to withdraw

3

Alvarez Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | individual

102

Number of other individuals to whom notice has been sent | individual

105

Percentage of graduates obtained job in field of study

90.00%

Stoltmann Case [Member]

Loss Contingencies [Line Items]

Number of other individuals filed lawsuit | lawsuit

399

Number Of Individuals to File Second Amended Claim | individual

1

Complaint 2017 And 2018 Case [Member]

Loss Contingencies [Line Items]

Qui Tam False Claims Act Actions Filed | lawsuit

2

Subsequent Event [Member] | Lawsuit In United States District Court for the Northern District of California

Loss Contingencies [Line Items]

Number of plaintiffs, unsettled

4

Segment Information (Tabulation

Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Jun. 30, 2020
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 283,111	$ 266,172	$ 551,352	$ 520,785
Total Consolidated Assets	2,244,664	2,390,610	2,244,664	2,390,610	$ 2,228,687
Total consolidated operating income excluding special items	52,567	42,266	106,932	69,758
Restructuring expense	(1,165)	(1,955)	(5,388)	(8,485)
Business acquisition and integration expense	11,079	0	24,515	0
Gain on sale of assets	0	0	0	4,779
Total consolidated operating income excluding special items	40,323	40,311	77,029	66,052
Net other income (expense)	(1,512)	(31,438)	(3,682)	(36,065)
Total consolidated income from continuing operations before income taxes	38,811	8,873	73,347	29,987
Total Consolidated capital expenditures	9,732	9,875	24,175	20,311
Total Consolidated Depreciation Expense	9,350	8,831	18,325	17,224
Total Consolidated Intangible Asset Amortization Expense	2,519	2,576	5,037	5,110
Medical and Healthcare [Member]
Segment Reporting Information [Line Items]
Restructuring expense		(417)		(544)
Financial Services [Member]
Segment Reporting Information [Line Items]
Restructuring expense	0	(1,137)	(1,415)	(3,116)
Home Office And Other [Member]
Segment Reporting Information [Line Items]
Restructuring expense	(1,165)	(401)	(3,973)	(4,825)
Operating Segments [Member] | Discontinued Operations, Held-for-sale [Member]
Segment Reporting Information [Line Items]
Total Consolidated Assets		629,837		629,837
Operating Segments [Member] | Medical and Healthcare [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	234,396	220,180	453,222	427,667
Total Consolidated Assets	987,276	913,359	987,276	913,359
Total consolidated operating income excluding special items	51,290	41,600	104,300	70,227
Total Consolidated capital expenditures	5,623	6,367	14,889	12,834
Total Consolidated Depreciation Expense	7,690	7,540	15,063	14,771
Operating Segments [Member] | Financial Services [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	48,715	45,992	98,130	93,118
Total Consolidated Assets	590,045	574,813	590,045	574,813
Total consolidated operating income excluding special items	7,793	5,679	16,480	9,786
Total Consolidated capital expenditures	2,344	873	4,471	1,412
Total Consolidated Depreciation Expense	800	588	1,529	882
Total Consolidated Intangible Asset Amortization Expense	2,519	2,576	5,037	5,110
Operating Segments [Member] | Home Office And Other [Member]
Segment Reporting Information [Line Items]
Total Consolidated Assets	667,343	272,601	667,343	272,601
Total consolidated operating income excluding special items	(6,516)	(5,013)	(13,848)	(10,255)
Total Consolidated capital expenditures	1,765	2,635	4,815	6,065
Total Consolidated Depreciation Expense	860	703	1,733	1,571
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Restructuring expense	(1,165)	(1,955)	(5,388)	(8,485)
Business acquisition and integration expense	(11,079)		(24,515)
Gain on sale of assets	$ 0	$ 0	$ 0	$ 4,779

Segment Information (Revenues a

Segment Information (Revenues and Long-Lived Assets by Geographic Area) (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 283,111	$ 266,172	$ 551,352	$ 520,785
Total Consolidated Long-lived Assets	378,699	364,825	378,699	364,825
Operating Segments [Member] | Domestic Operations [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	176,911	160,410	349,556	312,445
Total Consolidated Long-lived Assets	215,797	200,257	215,797	200,257
Operating Segments [Member] | Barbados, St. Kitts, and St. Maarten
Segment Reporting Information [Line Items]
Total Consolidated Revenue	92,419	94,705	177,480	185,675
Total Consolidated Long-lived Assets	161,825	162,813	161,825	162,813
Operating Segments [Member] | Other International Operations [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	13,781	11,057	24,316	22,665
Total Consolidated Long-lived Assets	1,077	1,755	1,077	1,755
Operating Segments [Member] | International Operations [Member]
Segment Reporting Information [Line Items]
Total Consolidated Revenue	106,200	105,762	201,796	208,340
Total Consolidated Long-lived Assets	$ 162,902	$ 164,568	$ 162,902	$ 164,568

Segment Information (Additional

Segment Information (Additional Information) (Detail)	6 Months Ended
	Dec. 31, 2020segment
Segment Reporting [Abstract]
Number of Reportable Segments	2